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Résumé en Français 
La barrière hémato-encéphalique (BHE) protège le système nerveux central (SNC) en 
contrôlant le passage des substances sanguines et des cellules immunitaires. La BHE est 
formée de cellules endothéliales liées ensemble par des jonctions serrées et ses fonctions 
sont maintenues par des astrocytes, celles ci sécrétant un nombre de facteurs essentiels. 
Une analyse protéomique de radeaux lipidiques de cellules endothéliales de la BHE 
humaine a identifié la présence de la voie de signalisation Hedgehog (Hh), une voie 
souvent liées à des processus de développement embryologique ainsi qu’au niveau des 
tissus adultes. Suite à nos expériences, j’ai déterminé que les astrocytes produisent et 
secrètent le ligand Sonic Hh (Shh) et que les cellules endothéliales humaines en cultures 
primaires expriment le récepteur Patched (Ptch)-1, le co-récepteur Smoothened (Smo) et 
le facteur de transcription Gli-1. De plus, l’activation de la voie Hh augmente l’étanchéité 
des cellules endothéliales de la BHE in vitro. Le blocage de l’activation de la voie Hh en 
utilisant l’antagoniste cyclopamine ainsi qu’en utilisant des souris Shh déficientes (-/-) 
diminue l’expression des protéines de jonctions serrées, claudin-5, occcludin, et ZO-1. La 
voie de signalisation s’est aussi montrée comme étant immunomodulatoire, puisque 
l’activation de la voie dans les cellules endothéliales de la BHE diminue l’expression de 
surface des molécules d’adhésion ICAM-1 et VCAM-1, ainsi que la sécrétion des 
chimiokines pro-inflammatoires IL-8/CXCL8 et MCP-1/CCL2, créant une diminution de 
la migration des lymphocytes CD4+ à travers une monocouche de cellules endothéliales 
de la BHE. Des traitements avec des cytokines pro-inflammatoires TNF-α and IFN-γ in 
vitro, augmente la production de Shh par les astrocytes ainsi que l’expression de surface 
de Ptch-1 et de Smo. Dans des lésions actives de la sclérose en plaques (SEP), où la BHE 
est plus perméable, les astrocytes hypertrophiques augmentent leur expression de Shh. 
Par contre, les cellules endothéliales de la BHE n’augmentent pas leur expression de 
Ptch-1 ou Smo, suggérant une dysfonction dans la voie de signalisation Hh. Ces résultats 
montrent que la voie de signalisation Hh promeut les propriétés de la BHE, et qu’un 
environnement d’inflammation pourrait potentiellement dérégler la BHE en affectant la 
voie de signalisation Hh des cellules endothéliales. 
 
Mots-clés : radeaux lipidiques, microdomaine, barrière hémato-encéphalique, jonctions serrées, astrocyte, 
cellule endothéliale, endothélium, perméabilité, voie de signalisation hedgehog, sonic hedgehog, sclérose 
en plaques, neuroimmunologie, neuroinflammation 
Résumé en Anglais 
The blood-brain barrier (BBB), composed of tightly bound endothelial cells (ECs), 
regulates the entry of blood-borne molecules and immune cells into the CNS. Recent 
studies indicate that the Hedgehog (Hh) signaling pathway in adult tissues plays an 
important role in vascular proliferation, differentiation and tissue repair. Using a lipid 
membrane raft-based proteomic approach, I have identified the Hedgehog (Hh) pathway 
as a signaling cascade involved in preserving and upkeeping BBB functions. My study 
shows that human astrocytes express and secrete Sonic Hh (Shh) and conversely, that 
human BBB-ECs bear the Hh receptor Patched-1 (Ptch-1), the signal transducer 
Smoothened (Smo) as well as transcription factors of the Gli family. Furthermore, 
activation of the Hh pathway in BBB-ECs restricts the passage of soluble tracers in vitro. 
By blocking the Hh signaling in vitro and by using Shh knock-out (-/-) embryonic mice, I 
demonstrate a reduced expression of TJ molecules claudin-5, occludin and ZO-1. Hh 
activation also decreases the surface expression of cell adhesion molecules ICAM-1 and 
VCAM-1, and decreases BBB-ECs secretion of pro-inflammatory chemokines IL-
8/CXCL8 and monocytes chemoattractant protein 1 MCP-1/CCL2, resulting in a 
reduction of migrating CD4+ lymphocytes across human BBB-EC monolayers. In vitro 
treatment with inflammatory cytokines TNF-α and IFN-γ, upregulates the production of 
astrocytic Shh and the BBB-EC surface expression of Ptch-1 and Smo. In active Multiple 
Sclerosis (MS) lesions, in which the BBB is disrupted, Shh expression is drastically 
upregulated in hypertrophic astrocytes, while Ptch-1 and Smo expression is down-
regulated or left unchanged, suggesting that a deregulation in the Hh signaling pathway 
may prevent the barrier stabilizing properties of Hh. Our data demonstrate an anti-
inflammatory and BBB-promoting effect of astrocyte-secreted Hh and suggest that a pro-
inflammatory environment disrupt the BBB by impacting, at least in part, on Hh 
signaling in brain ECs. 
 
Key words: lipid membrane raft, DRM, microdomain, blood-brain barrier, tight junction, astrocyte, 
endothelial cell, endothelium, permeability, hedgehog pathway, sonic hedgehog, Multiple Sclerosis 
neuroimmunology, neuroinflammation 
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The vascular system is composed of blood vessels that pervade through the entire 
body, transporting blood and providing nutrients, oxygen, and hormones to the tissues, 
while removing carbon dioxide and waste metabolites. Vascular development is typically 
divided into two separate stages. The first stage, vasculogenesis, is defined as the de novo 
formation of endothelial tubes from newly differentiated endothelial precursor cells 
(EPC), or angioblasts. Aggregations of two or more angioblasts initiate the process of 
vascular tube formation, also known as tubulogenesis1. Lumens are formed by fusion of 
intracellular vacuoles with cell membranes, enlarging the enclosed space between the 
cells and generating the appearance of clear slit-like spaces between angioblasts. 
Establishment of apical-basal cell polarity and interactions between angioblasts and 
surrounding extracellular matrix (ECM) are also important steps in establishing early 
vasculature2-4 The later stages of vasculogenesis include the formation of vascular 
channels and capillary plexus, which are then remodeled into a circulatory network via 
angiogenesis5. This second separate stage of vascular development is thus the subsequent 
growth, elaboration and remodeling of existing blood vessels to form a mature 
vasculature and is also, in general, the process of new blood vessel formation in the adult 
organism4,6,7. Once angiogenesis has ceased, vessel maturation begins.   
 
1.0 THE BLOOD-BRAIN BARRIER (BBB) 
1.1 Unique BBB properties 
 
Maturing endothelial cells (ECs) of the central nervous system (CNS) attain 
unique properties compared with those present in other organs, such as                              
high resistance intercellular complexes, low pinocytosis and specialized transport 
systems, leading to the formation of the blood-brain barrier (BBB), or barriergenesis 8,9. 
During this final developmental step of the brain vascular system, cerebral and spinal 
cord capillaries form a continuous cellular barrier, restricting the movement of 
electrolytes, xenobiotics and circulating immune cells between the systemic circulation 
and the CNS parenchyma in order to maintain an optimal milieu for neuronal functions. 
Low transcellular passage is a result of the loss of cell fenestration, and tightly adhering 
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junctions between BBB-ECs permit additional low paracellular diffusion10. These 
optimal BBB properties are achieved through intricate cellular interactions between 
BBB-ECs and perivascular glial cells, creating a dynamic neurovascular unit.  
In order to promote an optimal milieu for neuronal functioning, BBB-ECs also 
express highly active metabolic enzymes and numerous polarized transporters which 
regulate oxygen and nutrient transport to the CNS8,11. In fact, BBB-ECs contain abundant 
mitochondria, as compared to non-CNS ECs, reflecting the high energy demand required 
to achieve barrier functions8. These active transport systems include nutrient transporters 
(specific for glucose, amino acids, nucleoside, fatty acid, minerals and vitamins), peptides 
and protein transport systems (oligopeptide transporters, absorptive and receptor 
mediated endocytosis) as well as various ion transporters8,11,12. Thus, expression of BBB-
specific transporters, such as glucose transporter-1 (Glut-1), sodium/glucose co-
transporters and transferrin receptor (TfR), are necessary for proper nutrient transport 
from the blood to the CNS11. Many drug efflux pumps, such as P-glycoprotein, and 
Multiple drug resistance protein-1 (MRP-1), carry toxic substrates from the interstitial 
space of the CNS back to the blood and thus by restricting toxin accumulation within the 
CNS, provide an extremely important mechanism by which the BBB prevents damage to 
the brain13. 
Other molecular markers for in vivo and in vitro BBB-ECs exist, but few are 
specific to the brain vasculature, as they also reside on peripheral ECs, epithelial cells, or 
other CNS cells. To name a few, von Willebrand factor (vWF), a large multimeric 
glycoprotein, is selectively produced in ECs and is involved in coagulation14. The plant-
derived lectins Ulex europaeus agglutinin I and Lycopersicon esculentum are known to 
bind ECs and their uninterrupted staining are commonly used as a marker of EC and 
BBB integrity15,16. Other BBB-EC markers include tissue transglutaminase, 
Neurothelin/HT7/EMMPRIN, and γ-glutamyl transpeptidase (γGT), an enzyme involved 
in the catalytic transport of amino acids8,17-20. Antibodies directed against caveolin-1 also 
bind to ECs in vitro and in situ and can be used as a reliable marker of human CNS 
vessels21. Indeed, caveolin-1 is expressed throughout the CNS vasculature, is not vessel 
size-dependant nor substantially affected by inflammation and is only weakly expressed 
by perivascular astrocytes22,23.  
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1.1 Tight and adherens junctions 
 
Intercellular tight junctions (TJs) and adherens junctions (AJs) between BBB-ECs 
gradually restrict the passage of blood-borne molecules and cells from the blood to the 
CNS as the junctions mature24. TJ complexes are the main protein structures responsible 
for the barrier properties and are located at the apical, or luminal, plasma membrane 
between adjacent BBB-ECs. They are viewed to polarize the cell into its apical and 
basolateral domains, in addition to providing high transendothelial electrical resistance 
(TEER) and restrictive permeability25,26. TJs consist of at least three known types of 
integral/transmembrane proteins including occludin, claudins and the junctional adhesion 
molecules (JAMs)8,11,25-27. Occludin does not seem to be functionally required for the 
structural integrity or formation of the TJs as the occludin knock-out (-/-) animals 
developed normal TJs and functional BBB. However, other developmental abnormalities 
during development in the occludin -/- mice, such as aberrations in brain function and 
inflammation of the gastric epithelium, suggest that occludin may modulate TJs by other 
means28. Claudins, on the other hand, are members of a large family of proteins (over 20 
claudins) that share structural homologies with occludin and are reported to be essential 
TJ components29. Claudins create an impermeable seal between the cells through 
homophilic and heterophilic binding of their extracellular loops between adjacent cells. 
Claudin-1, -3, -5 and -12 are expressed in BBB-ECs and contribute to cerebral vessel 
impermeability30,31. In particular, claudin-5 is an essential TJ protein as in vivo 
permeability experiments in claudin-5 deficient mice demonstrated selective loss of BBB 
integrity to small molecules. Although the general morphology of blood vessels was not 
altered in these claudin-5 -/- animals, these mice died within hours of birth31. Claudin-3 
has also been observed to be selectively lost from BBB TJs under pathological conditions 
where BBB integrity is compromised, such as in experimental autoimmune 
encephalomyelitis (EAE) and in glioblastoma multiforme30,32. This suggests that claudin 
expression and function might be regulated by pro-inflammatory cytokines and in 
pathological conditions. The third protein reported to be part of TJ complex is JAM-1, 
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also known as JAM-A. JAM-A localizes within TJs and is involved in the recruitment 
and organization of the TJs, as its expression enhances the accumulation of zona 
occludens (ZO)-1 and occludin by linking to the actin cytoskeleton33. Recent reports 
described reduced JAM-A expression during the early phase of BBB breakdown, 
suggesting that JAM-A contributes to BBB integrity34. JAM-2 and -3 are also present in 
BBB-ECs11,35,36, but their contribution to TJ complexes and BBB integrity remains 
unclear.  
Occludin, claudins and JAMs interact with a variety of intracellular proteins and 
may therefore regulate a wide array of signaling pathways essential for TJ assembly, 
maintenance and regulation. In fact, the cytoplasmic region of transmembrane TJ 
complexes interacts with a vast number of adaptor proteins that allow binding of actin 
microfilaments to the TJ complexes while also acting as signaling molecules. ZO -1, -2 
and -3 are members of the membrane-associated guanylate kinase (MAGUK) protein 
family of adaptor proteins that contain many protein-protein interaction domains (such as 
SH3 and PDZ domains), which can interact with the cytoplasmic tail of TJ proteins and 
bind to other adaptor proteins, leading to the formation of intricate signaling scaffolding 
platforms27.  ZO-1 is important for TJ platform stability as disruption of ZO-1 correlates 
with loss of BBB properties15. In fact, the suppression of ZO-1 and ZO-2 in cultured 
epithelial cells lead to the cytoplasmic accumulation of claudins and absence of TJ 
formation37. Additional MAGUK proteins expressed by BBB-ECs include MAGUK 
inverted proteins (MAGI-1 and -3) and multi-PDZ protein (MUPP1)27. Well 
characterized signaling molecules, such as the small GTPases RhoA, Rac and Cdc42 
control actin cytoskeleton organization and are also involved in the maintenance of TJs38-
40. Overall, the expression levels of TJ proteins have been found to decrease in many 
neurological disorders that are characterized by the loss of BBB permeability integrity, 
such as in brain tumors, ischemia, and multiple sclerosis (MS)15,41-46. Additional putative 
TJ and intracellular adaptor proteins are still being identified and found to be associated 
with the junctional complexes, such as EMP-1 (epithelial membrane protein)47, LYRIC 
(LYsine-RIch CEACAM1)48, coxsackie adenovirus receptor (CAR)49, AF-650, 
cingulin27,51, CASK52 and 7H6 antigen53. The exact contributions of these molecules are 
yet to be established. 
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Another type of junction that contributes to BBB permeability and intermingles 
with the TJs in ECs is the adherens junction (AJ). AJs of BBB-ECs are primarily 
composed of platelet-endothelial cell adhesion molecule (PECAM)-1 and vascular 
endothelial cadherin (VE-cadherin) which interact with intracellular proteins, including 
the different catenins (isoform α, β, γ), ZO-1, p120 and desmoplankin, therefore creating 
an association with the actin cytoskeleton54-63. In addition, catenins are also crucial 
signaling molecules which can enter the nucleus and induce gene transcription upon AJ 
disruption64. AJ expression temporally precede the expression of TJs at intercellular 
contacts, and may be necessary for proper TJ formation as recent reports demonstrated 
that VE-cadherin expression and clustering modulates the activity of various transcription 
factors leading to an upregulation of claudin-5 gene transcription in ECs65. To 
summarize, the various proteins involved in the junctional complexes are illustrated in 
Figure i. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Claudin-3, -5, -12
Occludin
JAMs
Tight
junction
Adherens
junction
PECAM-1
VE-cadherin
ZO-2
ZO-3
ZO-1
Actin-based
cytoskeleton
α-, β-, γ-Catenin, p120,
Desmoplakin, ZO-1
Apical Membrane
Cingulin, CASK, 
7H6, MUPP1, 
MAGI-1, -2, -3
Basal Lamina
Figure i: Schematic illustration of the Tight and Adherens Junction of BBB-ECs. TJs are compromised of the 
transmembrane proteins occlduin and the claudins, which are similar in homolgy and JAMs. BBB-EC AJ consists mainly 
of PECAM-1 and VE-cadherin. The cytoplasmic region contains adaptor proetins which link TJ and AJ proteins to the 
actin cytoskeleton. ZO-1, through its protein-protein domain, can bind the cytosolic tails of transmembrane proteins. With 
the help of other cytosolic proteins, such as Cingulin, CASK, MAGIs, TJs can be associated to the cytoskeleton. Catenins 
are the main adaptor protein for AJs, interacting with additional proteins such as desmoplankin, p120 and ZO-1, to 
stabilize the junctions.
Figure i 16
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2.0 CUES IN THE VASCULATURE 
 
The cues and receptors most known to be involved in vasculogenesis and 
angiogenesis are largely specific to the cardiovascular system, such as vascular 
endothelial growth factor (VEGF) and components of the transforming growth factor 
(TGF)-β signaling pathway, angiopoietins (Ang)-1 and -266. VEGF and Ang-1 are potent 
mitogens and survival factors for the vasculature as they stimulate the initially scattered 
EPCs to proliferate, fuse together and form a primitive plexus of vessels that 
consequently enlarges and remodels, in the end, to develop into highly conserved organ-
specific vascular patterns7,66. For precise and functional vascular networks to be 
reproduced, additional signals assist in the temporal and spatial guidance and 
proliferation of cells within the developing vasculature, permitting pervasive navigation 
of blood vessels to their appropriate target sites and to acquire a mature vasculature that 
is functionally and elaborately adjusted to its organ-specific environment, such as the 
CNS. 
 
2.1 Glial cues control of the vasculature and blood-brain barrier function 
 
Barriergenesis and the unique EC properties in the CNS are not predetermined by 
brain-specific EPCs but are induced by the local neural environment during the 
development of the vascular system. Persistence of a functional BBB throughout 
adulthood is thus similarly maintained and regulated by numerous brain-derived 
factors11,67. The complex communication and diverse signaling events between BBB-ECs 
and surrounding astrocytes, pericytes and microglia, allow for regulated BBB functions 
and promote TJ maintenance, metabolic and specialized transporter expression as well as 
immune quiescence of the brain ECs68. These proximate signals also promote rapid 
regulation and remodeling of the BBB, a phenomena crucial for maintaining CNS 
homeostasis in response to physiological and pathological stimuli8,11,15,21,24,45,69-72. One 
relatively important cellular component of the neurovascular unit comprises of pericytes 
which are believed to play a role in the maturation and maintenance of the BBB by 
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secreting growth factors and producing ECM constituents73. Pericytes contact ECs via N-
cadherin-dependent binding74, and are reported to secrete TGF-β75, Ang-1 and -276,77, and 
platelet-derived growth factor (PDGF)78, which promote vascular maturation, integrity 
and BBB impermeability76. Although pericytic abnormalities and dysfunctions have been 
associated with CNS pathologies such as hypertension, Alzheimer’s disease and stroke, 
their exact nature and function in regards to the BBB remain under investigation73,76,77. 
Other cellular constituents of the neurovascular unit which are crucial inducers of 
BBB properties are the astrocytes. Astrocyte-BBB-EC interactions are known to regulate 
vascular proliferation, angiogenesis, transporter protein expression, TJ protein expression 
and morphology and finally, inflammatory responses in the brain8,11,32,43,68,71,79-83. 
Astrocytic endfeet, separated only by a thin, but compact basal lamina, contact and 
ensheathe the entire surface of brain and spinal cord blood vessels84,85. The importance of 
astrocytes on BBB properties becomes clear when BBB-ECs are isolated and cultured in 
vitro in the absence of astrocytes. BBB-derived ECs rapidly lose some of their barrier 
characteristics, such as P-glycoprotein and TfR expression86,87. BBB function can be 
reinstated by co-culturing BBB-derived ECs in the presence of astrocytes or 
supplementation of astrocyte-conditioned media (ACM)43,88,89. Conversely, culturing 
non-neural ECs in the presence of astrocytes, or astrocyte-secreted factors, induces BBB-
specific properties, such as P-glycoprotein and TJ expression11,68,81,90. These observations 
underscore the importance of signals provided by astrocytes and provide evidence that 
factors needed for reliable BBB function are at least partly soluble and secreted91. A 
number of studies have identified a variety of soluble and contact-dependent factors 
provided by astrocytes. Taken together, the microenvironment of the healthy brain and 
cellular interactions within the neurovascular unit provide inductive and maintenance 
signals for the BBB.  
Astrocytes can be induced to secrete classic angiogenic factors that are important 
in vascular growth. VEGF, primarily acting through Flk1 receptor, is a potent mitogen for 
endothelial cells92 and is required for the formation, remodeling and survival of 
embryonic blood vessels as VEGF deficient embryos develop few or no angioblasts and 
die prematurely93. Later in development and adulthood, astrocyte-derived VEGF can be 
induced under hypoxic conditions94 to stimulate angiogenesis and, in consequence, 
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provokes BBB disruption95-97. On the other hand, Ang-1 and -2 bind to the receptor 
tyrosine kinase Tie-2 on ECs. Whilst Ang-2 activates angiogenesis and is expressed in 
early phases of BBB breakdown98, Ang-1 is involved in vascular maturation and 
quiescence, events that are characteristic of BBB differentiation99,100. In fact, Ang-1 
causes a time- and dose-dependent decrease in endothelial permeability by upregulating 
TJ expression100. Astrocyte-secreted thrombospondin (TSP)-1 and -2 also have anti-
angiogenic properties, inhibiting EC proliferation and has been suggested to promote 
vascular maturation101. Thus, a balance between angiogenic and BBB promoting agents 
occurs at the level of brain ECs. 
Additional potential cues that promote BBB maintenance include members of the 
fibroblast growth factor (FGF) family which have the ability to decrease EC 
permeability102,103. In fact, FGF-2 and -5 -/- mice have decreased occludin and ZO-1 
expression and show defects in barrier functions103. Astrocytic secretion of glia-derived 
neurotropic factor (GDNF) has also been seen to increase BBB integrity via its ligation to 
EC-expressed GDNF receptor α1104. Src suppressed C kinase substrate, also known as 
SSeCKS, produced by astrocytes, regulates angiogenesis, by decreasing the expression of 
VEGF and stimulates expression of Ang-1, augments ZO-1 and claudin-1 protein 
expression and decreases cerebral EC monolayers permeability 81. Additional novel 
astrocytic factors, recently identified by Dr. Kim and colleagues, include meteorin and A-
kinase anchor protein-12 (AKAP12), both which are capable of regulating barrier 
development and formation via induction of TSP-1 and-2 expression and reduction of 
angiogenic factor secretion101,105. TGF-β, a well known lymphocyte-produced cytokine 
with multiple and complex physiological functions, is also known to be secreted by 
astrocytes and ECs and to induce a downregulation of the level of leukocyte migration 
across ECs in vitro and in vivo in a dose-dependent manner106-108. Finally, work by Wosik 
and colleagues have shown that astrocytes secrete angiotensinogen and angiotensin II 
(AngII) which decreases BBB permeability. Angiotensinogen -/- mice have a diminished 
expression of occludin and disorganized TJ strands in brain capillaries, supporting the 
notion that AngII is involved in the formation of BBB-EC TJs43. Therefore, the current 
view is that astrocytes are key regulators of BBB development, maintenance and 
regulation and that understanding the complex astrocyte-BBB-EC interactions under 
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physiological and pathological conditions may lead to the development of novel 
therapeutic strategies. 
 
2.2 Neural cues control of the vasculature  
 
The search for additional cues that could potentially promote barrier formation 
can benefit from drawing on similar processes which utilizes signaling molecules. Prior 
to barriergenesis, vascular development requires directional guidance to establish a 
precise, conserved branching pattern in the vertebrate body, including those in the brain9. 
Due to the nutrient and oxygen demand of neurons, the development of the vascular 
system is interconnected to the development of the nervous system. Recent evidence 
suggests that blood vessels and nerves share common mechanisms to expand, navigate 
and mature during development, as well as post-natally109-111. In fact, some neurons 
follow the path of blood vessels and inversely, the differentiation and branching of 
certain blood vessel depends on the emergence of new neural circuits112,113. It is now 
clear, that many guidance cues, first found and characterized for their function in neural 
development, are recently also recognized to function during vascular development. The 
vascular network shares much of the extensively studied neuronal navigational methods 
to guide its blood vessels and many parallels have been drawn between the two systems. 
In neurons, the growth cone at the tip of the axon is a highly motile structure that 
explores the microenvironment by extending finger-like filopodia and veil-like 
lamellipodia. These extensions contain guidance cue receptors that have the potential to 
activate various signaling cascades affecting the arrangement and composition of the 
cytoskeleton and therefore impact on the directional movement and elaboration of the 
growing axon114. Recent studies have shown that in nascent capillary sprouts, endothelial 
tip cells can be seen as the vascular equivalent of the growth cone as they act as sensors, 
signal transducers and motility devices than can regulate extension of capillary sprouts109. 
Although tip cells proliferate minimally, endothelial stalk cells further down the sprout, 
divide to generate new vessels along the path chosen by the tip cell115. Like the axonal 
growth cone, the tip cells can extend filopodia and sense guidance cues in ECM or on 
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neighboring cells that dictate the direction of growth of sprouting capillary. Fusion of tip 
cells and lumen formation allows the generation of new vessels. Interestingly, both 
vessels and axons respond not only express but to common cues109-112. 
The long search for morphogens and guidance cues culminated in the 
identification of several highly conserved, distinct but multifunctional protein families. 
Members of the Wnt, Hedgehog (Hh), FGF and bone morphogenic protein (BMP) 
families were shown to act as classical morphogens in a number of different contexts. On 
the other hand, proteins of the Netrin, Slit, Ephrin and Semaphorin families were found to 
act as guidance cues for migrating cells and axons. Morphogens are expressed early in 
development in spatially very distinct patterns. Through the formation of gradients (for 
example along a developing body- or organ-axis), morphogens can directly induce 
different cell fates in a concentration-dependent manner. Thus, morphogens govern the 
pattern of tissue development and the position of various specialized cell types within a 
tissue116,117. Diffusible or cell surface-bound guidance cues can attract, repel or induce 
turning of growing axons and thus aid in the pathfinding process of neurons118-120. With 
recent studies, axon guidance functions have now been documented for members of each 
of the three major families of classical morphogens: Hhs, BMPs and Wnts, clearly 
demonstrating the complexity of these developmental cues121-123. In addition to these 
groups of major signaling molecules being active in early developmental processes, they 
are utilised repeatedly in a variety of different organs and systems. 
Most of the morphogenic/guidance pathways have been studied in other 
angiogenic processes109,124-129. EC differentiation and vascular morphogenesis are 
dependent on morphogenic factors such as Hh, Wnt and BMP127,130,131. Furthermore, Hh 
has been associated with several stages of vascular development, which will be reviewed 
later on (section 3.0). In analogy to the growth cone, the extending filopodia of the 
endothelial tip cell express Netrin-receptor UNC5, Slit-receptor Robo4, and Ephrin-
receptors EphA and B, interpreting signals as attractive or repulsive when blood vessels 
navigate in through environment129,132,133. For example, loss of UNC5H2/B or Netrin-1 in 
mice and zebrafish lead to abnormal vessel guidance and excessive vessel branching, 
suggesting they provide critical repulsive guidance for navigating blood vessels124,134. 
Netrin-4, however, seemed to be involved in angiogenesis after ischemic injury as it 
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upregulates in astrocytic endfeet and blood vessels 135. Similarly, Slit-2 inhibits the 
migration of Robo4-expressing ECs, while attracting ECs expressing the receptor 
Robo1125,133. EphrinB2 seems to provide a repulsive cue for intersomitic vessels136. In 
addition, Sema4D was seen to actually induce blood vessel formation, tubologenesis on 
top of EC migration. In fact, Semaphorin receptor Neuropilin-1 has now been recognized 
as a co-receptor for VEGF isoforms, suggesting complex interactions between vascular 
and axonal networking137,138. In fact, capillary sprouts radially invade the developing 
neuroectoderm along concentration gradients of VEGF113. While angiogenic factors are 
seen to act as chemoattractant cues, guidance and morphogenic cues can, on the other 
hand, act as angiogenic factors. Netrin-4 can increase blood-vessel density by enhancing 
blood vessel proliferation135 and BMP2 can both play a chemotactic role on angioblasts 
and microvascular ECs as well as stimulating their proliferation and inducing tube 
formation139. While EphrinB2/EphB4 deletion resulted in a general failure in angiogenic 
remodeling of vascular plexus, EphrinA1 may regulate post-natal angiogenesis129. 
However, much controversy remains in this new area of research, concerning the 
expression and function of axonal guidance cues in angiogenesis and EC maintenance. 
This recycling of molecules during development suggests that these 
multifunctional proteins act globally in providing positional information in a variety of 
developmental processes such as embryonic patterning, CNS induction, and 
angiogenesis. In addition, many of these morphogens and axon guidance cues are also 
important in post-natal and adult processes that utilize and recapitulate embryonic 
processes such as maintenance of organotypic tissue, remodeling after repair and 
barriergenesis.  
 
2.3 Neural cues control of blood-brain barrier function 
 
Due to the close interaction of BBB-ECs with CNS processes, it is perhaps not 
surprising that cues typically associated with neural processes have thus been shown to 
impact on BBB-ECs. As mentioned previously, FGF-2 and -5 -/- mice have decreased 
occludin and ZO-1 expression and show defects in barrier functions103. BMP signaling 
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has also been seen to be important in astrocyte-endothelial interactions, where the loss of 
the receptor BMPR1a leads to an increase in leakage of Evans Blue and 
immunoglobulins (class G; IgG) through cortical vessels in vivo140. Stimulation of Robo4 
on ECs with its ligand Slit-2 induced barrier function in vitro. In vivo, Slit-2 prevented 
VEGF-induced hyperpermeability and Evans Blue leakage into tissues, implying their 
role in vascular bed maturation133. Recent studies have shown that the canonical Wnt 
pathway is important for vascular development and for the formation of a mature BBB141-
143. The Wnts are secreted glycoproteins that accumulate in the ECM that trigger 
activation of the Frizzled receptor on adjacent cells.  Frizzled activation promotes β-
catenin stabilization and entrance into the nucleus, where it can modulate target gene 
transcription. The Wnt pathway is activated in brain ECs during embryogenesis, where it 
is required for CNS angiogenesis and capillary bed formation141. Together, Wnt 7a and 
7b, together, are essential for CNS vascular development as Wnt7a/b double -/- mice 
display severe CNS-specific hemorrhaging and enhanced vascular fragility through 
destabilization of inter-endothelial contacts144. In vitro, Wnt3a induces claudin-3 
upregulation in mice brain vascular ECs142 and Wnt7a elicits strong migration of mouse 
brain ECs across a Boyden chamber filter and induces the expression of BBB-specific 
transporter Glut-1141. Post-natally, conditional loss-of-function of B-catenin in mouse 
ECs has decreases claudin-3 expression and Evans Blue extravasation in the CNS-
parenchyma142. Additional studies on CNS-related signaling molecules could potentially 
lead to identifying other BBB promoting factors. 
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3.0 THE HEDGEHOG (Hh) SIGNALING PATHWAY 
 
The Hh pathway is a conserved signaling cascade involved in embryonic 
morphogenesis, pathfinding, and as recent studies show, angiogenesis. There are three 
vertebrae homologues of the originally identified Hh in Drosophila melanogaster: Desert Hh 
(Dhh), Indian Hh (Ihh) and Sonic Hh (Shh). All three activate the same signaling pathway and 
the presence of divergent regulatory elements cause spatial and temporal differences in their 
expression patterns during embryogenesis145-149. While Ihh and Dhh are best known for their 
importance in chondrocyte and gonadal differentiation respectively146, Shh has been widely 
associated with morphogenic events such as posterior identity of the limb bud150, ventral cell 
identity of the neural tube, and motor neuron development151,152. As other morphogens, Shh 
has also been characterized as an axonal guidance cue, capable of both stimulating 
commissural axon migration towards the floorplate 121,122 and repelling them after the axons 
have crossed the floor plate and turned rostrally153. Recent studies suggest that the Hh pathway 
may also play an important role in adult tissue homeostasis, neural progenitor proliferation and 
wound healing, which all draws parallels to the embryonic developmental processes 130,154.  
Shh is initially translated as a ~45kDa precursor protein. Essential to Hh signaling is the 
internal autocatalytic cleavage of the 45kDa protein mediated by the carboxy (C)-terminal of 
Hh, yielding two products, the ~25kDa C-terminal fragment and the ~20kDa amino (N)-
terminal signaling domain. During autoproteolysis of the precursor protein, the C-terminal 
fragment becomes a functionally active cholesterol transferase that covalently adds a 
cholesterol molecule to the C-terminus of the N-terminal fragment. A palmitoyl moiety is also 
added to the N-terminal of the processed signaling molecule by Skinny Hh 145,155,156. These two 
lipid modifications control, in part, the ability of the Hh molecule to bind to its receptor and to 
signal at short- or long range. Following the post-translational addition of cholesterol and 
palmitoyl moieties, Shh is released from the producing cell with the help of the 12-
transmembrane protein Dispatched130. Tethered to the cell surface or secreted, Shh binds with 
high affinity to the cell surface receptor Patched (Ptch-1)-1, a 12-transmembrane domain 
receptor. In mammals, Ptch-2 has been isolated but not much is known about its exact role in 
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the signaling pathway157. Binding of Shh to Ptch-1 alleviates repression of the signal 
transducer Smoothened (Smo), a serpentine transmembrane protein with a topology 
reminiscent of Frizzled family of Wnt receptors and other G-protein coupled receptors158. 
Although the exact mechanism in which Ptch-1 inhibits or activates Smo is unknown, it is 
speculated that Smo is regulated by an undiscovered small molecule, such as oxysterols or 
vitamin D3 that would induce conformational changes within Smo159-161. The interaction of Hh 
with Ptch-1 can be promoted by its binding to two other transmembrane proteins Boc and 
Cdon. Several other surface proteins can bind, mobilize and limit the range of Shh movement 
such as Hip (Hh interacting protein), a membrane bound glycoprotein which sequesters Hh 
ligands, but has no effect on Smo activity and thus attenuates the signal162. Once Smo is in its 
active conformation, activation of zinc-finger transcription factors of the Gli family (Gli-1 
through -3) act at the last step of the Shh-signal-transduction pathway145,147 (Figure ii). 
Activation of cytoplasmic-bound Gli components is achieved through their sequential 
phosphorylation by various kinases, allowing them to translocate into the nucleus and induce 
or repress transcription of target genes. Elegant genetic studies have exposed both the 
redundant and unique functions of the three Gli transcription factors. Gli-1 and Gli-2 act 
primarily as activators, while Gli-3 can undergo autoproteolysis to function as a transcriptional 
repressor. Thus, the ratio of the Gli activator to Gli repressor forms of the proteins is critical in 
final transcription processes163. In addition to the induction of specific cell fate determinants in 
response to the Hh signal received, proteins of the Hh cascade itself, such as Ptch-1, Hip and 
Gli-1 are upregulated. It is thought that this positive feedback upregulation of expression 
results in increased levels of Ptch-1 and Hip protein at the cell membrane, further sequestering 
Hh and limiting spreading of the signal 146,147,164. Therefore, Ptch-1, Hip and more often, Gli-1 
mRNA or protein upregulation assays are used as indicators of Hh pathway activation. 
Given that Hh signaling is a critical developmental pathway during embryogenesis and 
organogenesis, mutations in pathway components result in congenital defects. The forebrain of 
the fetal Shh mutant fails to develop into two hemispheres, or holoprosencephaly, resulting in 
defects in the development of proper brain structures and functions as well as facial properties 
150,165. In human foetuses, loss of one Shh allele is enough to cause varying penetrance up to 
and including cyclopia (fusion of developing eyes at the midline), whereas both alleles need to 
be lost in the Shh -/- mouse to produce the same phenotype166-169. In mouse embryos, deletion 
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of Shh leads to cyclopia and defects in ventral neural tube, somite and foregut patterning. At 
later developmental stages, defects include severe distal limb malformations and failure of lung 
branching150,170,171.  
In addition to the vital role Hh plays in embryonic development, Hh signaling also 
functions as a regulator of cell proliferation, differentiation and survival in adult tissue. The 
importance of Hh functions, in the adult, is reflected in the loss of growth control when the 
pathway is damaged. Studies have shown that inappropriate reactivation of this pathway later 
in life can lead to the development of malignancies as Hh signaling is a molecular hallmark of 
several subsets of familial and sporadic tumors, including basal cell carcinoma syndrome172, 
medullablastoma146,173, pancreatic174, breast175, prostate176, gastrointestinal177 and lung 
cancers178,179. In addition, the family of Gli genes are named for their role in glioblastoma 
formations180. 
The highly teratogenic steroidal alkaloid toxins, cyclopamine and jervine, are extracted 
from corn lilies. Early gestating sheep grazing on wild corn lilies resulted in severe nervous 
system defects in their offspring that exhibited strong resemblances to holoprosencephaly with 
associated cyclopia. The toxins were later characterized to act as antagonistic compounds 
binding Smo and inhibiting Hh signaling181. Pertussis toxin (PTX) has also been seen to inhibit 
Smo activity through its ability to prevent G proteins from interacting with their G protein-
coupled receptors, even though no known G protein has been shown to bind to G-protein-
coupled receptor-like Smo182. High-throughput screens of chemical libraries for Hh pathway 
modulators have identified four compounds that potentially inhibit Shh (Smo antagonist, 
SANT-1 through SANT-4) and two that activate Hh signaling (Smo agonist, SAG and 
purmorphamine), both by binding directly to Smo (Figure ii) 183,184. Of the antagonists, SANT-
1 was found to exhibit the highest affinity for Smo and attenuated Shh stimulation to a much 
greater extent than the other antagonists183. 
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Figure ii: The Hedgehog signaling pathway A. In absence of Hh ligand,
Patched-1 (Ptch1), a 12 transmembrane domain receptor inhibits the 7-trans-
membrane G-coupled receptor Smoothened (Smo). B. In presence of Hh ligand,
Sonic Hedgehog (Shh) binds Ptch-1 which releases its inhibition on Smo, 
allowing it to activate transcriptional factors of the Gli family (Gli-1 and -2) and 
transcribing target genes. The antagonists Cyclopamine and SANT-1 blocks the 
activation of the Smo, thus inactivating the Hh pathway. The agonist 
purmorphamine activates Smo, thus activating the Hh signaling pathway.
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3.1 The Hh signaling pathway in vasculogenesis 
 
As other morphogens and axonal guidance cues, the Hh pathway has been associated 
with the vascular system. In the developing embryo, the visceral yolk sac is the first site of 
blood vessel formation in the murine embryo. Ihh was shown to regulate murine yolk sac 
angiogenesis as the Ihh -/- mice, as well as Smo -/- or cyclopamine-treated murine yolk sacs 
formed smaller, flattened, disorganized vessels that easily collapsed7,130,185. Smo deficient 
embryos display a more severely abnormal yolk sac phenotype than do Ihh -/-, suggesting that 
Shh may compensate for the loss of Ihh, but that it is not completely redundant185. In zebrafish 
models, Shh signaling is crucial for the organization of the angioblasts into major vascular 
channels such as the aorta and axial vein186,187. Similarly, in avian and mouse embryos, Shh 
and Ihh act together to mediate embryonic formation of aortic and coronary vessels4,187,188. 
Vokes and colleagues4 remarked that the first blood vessels within the embryo always formed 
in the mesoderm tissue in close proximity to the endoderm, and that an endodermic signal was 
essential for the assembly of angioblasts into tubular vessels. While VEGF treatment was not 
sufficient in inducing tubulogenesis in embryos lacking an endoderm, Shh was both found to 
be produced by the endoderm and to promote the assembly of angioblasts into vessel tubes. 
This elegant study showed that while VEGF was important in EPC differentiation, Shh 
signaling was crucial for the structural morphological formation of the vessels. Although at 
first, no obvious vascular defects were observed in Shh deficient mouse embryos150, other 
groups have now described decreased and abnormal vascularization in tissues such as the lung, 
heart, pharynx, and pulmonary tissue171,189. Cyclopamine-treated embryos exhibited a variety 
of vascular abnormalities such as interrupted tubes, unassembled clusters of angioblasts and 
fewer vessel tubes, compared to control embryos4. In embryos treated with cyclopamine at 
embryonic stage E8.5-10.5, neural tube angiogenesis was also impaired, as perineurial vascular 
plexus vessel sprouting does not occur190. On the other hand, hypervascularization of 
neuroectoderm occurred in response to Shh overexpression in the dorsal neural tube of zebra 
fish191 and overexpression of Shh by injection of Shh mRNA causes the formation of 
lumenized ectopic vessels187.  
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3.2 The Hh signaling pathway in angiogenesis 
 
During angiogenesis, remodelling of the vasculature is a process that depends on 
migration and reassembly of ECs. Through Smo activation, Shh can provoke cell morphology 
alterations together with formation of lamellipodia, suggesting a migratory response192. 
Furthermore, embryonic mouse yolk sac ECs responded to Shh treatment by activation of gene 
transcription involved in cytoskeletal organization, migration, and angiogenesis, as detected by 
GeneChip assays193. Wound healing is often seen as a recapitulation of angiogenesis as it 
requires recruitment of EPCs and endothelial tip cell chemoattraction to the target area154,193. 
Added exogenously, Shh significantly enhances wound healing and migration of embryonic 
ECs in wounded areas in a scratch assay, a process mediated through migration rather than 
cellular proliferation193. In an in vivo study of wound healing in mice, Shh treatment resulted in 
smaller wounds after 5 days, compared to control, a possible result of bone-marrow derived 
EPC recruitment, increased cellular infiltration, collagen deposition and enhanced overall 
vascularity in the wounded area154. As a morphogen, it is perhaps expected that several in vitro 
studies have shown that in addition to migration, Shh binding to Ptch-1 mediates capillary 
formation and morphogenesis, in mature murine brain capillary ECs, HUVECs and putative 
angioblasts from the bone marrow4,154,182. In these cells, Shh treatment increased nuclear Gli-1 
localization and mediates gene transcription and protein synthesis as actinomycin D and 
cycloheximide, respectively, inhibit capillary morphogenesis. Cyclopamine and PTX also 
suppress Shh-inducing capillary morphogenesis182. By augmenting cytoplasmic extensions and 
increasing cellular contacts between cells, Shh promotes cell type specific cellular adhesion 
which is important in structure formation. Similar models in drosophila proposed Hh-mediated 
cell adhesion pathways as a mechanism of wing imaginal disc formation194. 
Shh signaling stimulates vascular remodelling and angiogenesis in various tissues at 
later developmental stages195. Decreased levels of Shh signaling as a result of treatment of 
mice with a Shh neutralizing antibody or with cyclopamine leads to angiogenic malformation 
and loss of ability of existing vessels to remodel, fuse and form branches, causing 
malformations and haemorrhages. In particular, Shh-supported processes such as the 
development of branchial region vessels and pulmonary arteries are defective in Shh null mice 
embryos196. Postnatal and adult angiogenesis can also be enhanced by Hh signaling. Ptch-1 was 
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also found to be normally expressed in cardiovascular tissues of juvenile and adult mice and 
activation of Hh signaling in the adult heart is sufficient to promote coronary 
neovascularization and protect from ischemia, implying an important role for Shh in 
maintaining cardiac homeostasis and function. Temporal and tissue-specific deletion of Smo 
lead to reductions in proangiogenic gene expression and loss of coronary vasculature, which 
resulted in tissue hypoxia, cardiomyocyte apoptosis, ventricular failure and subsequent 
lethality197,198. When Shh is administered to aged mice, new vessel growth can be observed in 
adult corneas and ischemic hind limbs. Indeed, Shh treatment can promote an increase in 
capillary density, blood flow and vessel diameter, suggesting neovascularization199. Similarly, 
implantation of Shh-containing pellets promotes neovascularization and formation of large, 
well-organized branched vessels in corneal angiogenesis assays in mice199,200. In perspective, 
the Hh pathway possibly aids in tumor angiogenesis. The fact that the usually high expression 
of Hip on ECs is diminished in cancers supports the hypothesis that Hh is enhanced in tumor 
tissues and contributes to tumor angiogenesis and growth201. 
Shh not only can be viewed as a potent angiogenic agent, but activation of the Hh 
pathway can also have an indirect role in angiogenesis, by acting upstream of angiogenic 
factors. One of the first publications on the Hh pathway in angiogenic processes describes the 
ability of Shh to upregulate angiogenic factors such as VEGF (all three isoforms of VEGF-1, -
189, -165, -121) and both Ang-1 and Ang-2 in mesenchymal fibroblasts, possibly placing Hh 
upstream of these vascular-specific growth factors and vessel stabilization potentials199. 
However, Shh treatment did not seem to have an effect of EC migration and proliferation, 
implying that EC response may be dependent on their differentiation status, developmental age 
and organ origin193,199. Since, others have observed VEGF and Ang-1 upregulation in other 
contexts, such as in Shh-treatment of human EC lines202, and coronary vasculature198. Blocking 
Shh with neutralising antibodies or cyclopamine inhibits VEGF upregulation and thus 
angiogenesis, as seen in mouse models of hind limb and cornea ischemia199,203. Ang-1 and its 
receptor Tie-2 are even downregulated in the lungs of Shh -/- embryos204. These studies 
suggest that the Hh signaling pathway is important in vascular proliferation and differentiation 
as well as in vitro capillary morphogenesis. 
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3.3 Evidence of the Hh signaling pathway in barrier function 
 
Little is known for the Hh signaling pathway during the last step of vasculature 
maturation, barriergenesis. In the developing mouse submandibular gland, lumen formation 
occurs in the epithelial cell lining, leading to the establishment of apical-basal polarity and TJ 
formation, processes reminiscent of EC barrier formation. Shh null mice exhibit 
developmentally arrested submandibular gland epithelium, whereas treatment with Shh 
enhances epithelial lumen formation, full cell polarization and ZO-1, claudin-3 and occludin TJ 
protein distribution in these deficient explants205. In addition, laminin-5 deposition at the basal 
lamina region of terminal buds was accelerated in Shh-treated glands205, suggesting a role of 
Shh in both junctional and extracellular cell attachment. Importantly also, in the peripheral 
nervous system (PNS), Dhh is expressed in myelinating Schwann cells. This Dhh signal is 
needed for the formation and maintenance of the perineurium, a component of the blood-nerve 
barrier that acts as a barrier to protect against serum molecules and cellular infiltration206. 
Comparable to the endothelial lining of blood vessels, perineurial cells are sealed by tight and 
gap junctions and are supported by a prominent basal lamina, thus forming an effective 
diffusion barrier. In Dhh -/- animals, the perineurium is looser, and the basal lamina encloses 
less collagen and is overall discontinuous. In addition, perineurial cells of Dhh null mice lack 
the gap junction protein connexion43, while expression of TJ proteins occludin and ZO-1 is 
disorganized. Freeze fracture electron microscopy further revealed abnormal and interrupted TJ 
arrays in Dhh null mice when compared to normal control perineurium TJ strands, leading to a 
defective nerve-tissue barrier, shown by extravasation of Evans Blue dye and immune cells 
invasion into the endoneurium206. Similarly, after a crush injury, more macrophage infiltrations 
is visible in both injured and non-injured nerves in Dhh -/- mice207. Therefore, the Hh pathway 
is likely to be involved in the formation of an ordered and functionally competent perineurium, 
seen as a later stage of perineurial sheath maturation208. By analogy, these studies raise the 
question of whether the Hh pathway plays a role in other barrier contexts, such as the BBB.  
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4.0 THE BASAL LAMINA 
 
The basal lamina, found between the BBB-ECs and perivascular cells, is 
composed of several ECM components, including fibronectin, laminins, collagen type IV 
and heparin sulfate proteoglycans209-211. The basal lamina functions as a tissue boundary 
on which cells are attached to and a substrate for cellular differentiation and induction of 
gene expression. Astrocyte, and to a lesser degree, pericyte-derived ECMs enhanced 
BBB integrity, demonstrating the importance of additional glial matrix 
constituents209,211,212. For example, astrocytes can express agrin which could serve as a 
basal membrane factor maintaining barrier functions, as loss of agrin in human glioma 
accompanied a loss in TJ8,213. In addition, soluble factors secreted by glial cells can be 
captured by ECM proteins, and thus increase their local concentrations. BBB-ECs, in 
return, constitutively express a number of integrins that are important for EC adhesion to 
the basal lamina and control many signaling events critical for cell survival, growth and 
gene expression210,214,215. Integrins are heterodimers of α- and β- integrin and pairs such 
as α1β1, α3β1 and α6β1 are commonly expressed on the cerebrovasculature and recognize 
the basal lamina. Alterations in expression of integrins have been shown to correlate with 
angiogenesis, BBB breakdown and increased barrier permeability during focal cerebral 
ischemia and/or MS. For instance, appearance of αvβ3 on BBB-ECs was found to be 
significantly upregulated after the onset of focal ischemia 210,214. This suggests that 
integrin receptor function is needed for the maintenance of the BBB.  
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5.0 IMMUNE INTERACTIONS AT THE BBB  
 
Under physiological conditions, a low number of immune cells, or leukocytes, 
continuously cross the BBB and monitor the CNS in a process called immune 
surveillance. The BBB-ECs are, thus, the first cells leukocytes must contact before 
entering the CNS and the molecular mechanisms by which leukocytes accomplish 
transendothelial migration is complex and involves a series of sequential and tightly 
controlled steps216. Initially, leukocyte rolling consists of a weak interaction between EC 
selectins, or cell adhesion molecules (CAMs), and their ligands on leukocytes. Since the 
CAM-ligand interaction is originally one of low-affinity, leukocytes can roll along the 
blood-vessel wall and sense activation factors deposited on the EC surface, such as 
various chemokines217.  
During inflammatory conditions, BBB-ECs can actively influence and participate 
in neuroinflammatory reactions by regulating cytokine/chemokine and CAM expression, 
both directly affecting immune cell migration into the CNS218-221. In addition to the ECs, 
CNS parenchymal cells can become activated by inflammatory cytokines to secrete 
chemokines in their vicinity. With over 50 identified members, chemokines constitute a 
large group of small cytokines (chemotactic cytokines) which are classified, according to 
their cystein configuration, into two main families, the CC and CXC chemokines. In 
response to inflammatory challenge, BBB-ECs can produce and secrete pro-inflammatory 
among others, monocyte chemoattractant protein (MCP)-1, also known as CC ligand 
(CCL)-2, MIP-1α/CCL3, RANTES/CCL5, interleukin (IL)-8/CXCL8, and IP-
10/CXCL10217,222-224. However, MCP-1/CCL2 and IL-8/CXCL8 were seen as the major 
chemokines produced by BBB-ECs grown under culture conditions and upregulated upon 
inflammatory conditions225. All these chemokines bind specific G-protein coupled 
receptors on the leukocytes, rapidly inducing integrin conformational changes through an 
outside-in signaling mechanism that promote their high-affinity interactions to the cell 
CAMs expressed on BBB-ECs.217  
In addition to the tight adherence, EC expression of CAMs and leukocyte 
integrins also mediate the ensuing diapedesis of immune cell across vascular beds. Under 
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normal conditions, CNS-ECs express low levels of all the appropriate CAMs, such as 
intercellular CAM-1 (ICAM-1) and vascular CAM-1 (VCAM-1)226-228. However, in the 
presence of inflammation, these molecules are strongly upregulated, further promoting 
leukocyte arrest and transmigration. Recent studies have identified additional CAMs that 
regulate the transmigration of lymphocytes EC barriers by the means of ALCAM 
(activated leukocyte cell adhesion molecule or CD166)23 and Ninjurin-1 229 which, for 
example, play important roles in invasion of particular subsets of leukocytes such as 
CD4+ T cells and monocytes, respectively, from the blood to the CNS, especially during 
inflammatory contexts. 
The final step of immune cell transmigration across the BBB consists of arrested 
leukocytes crawling along the surface of inflamed endothelium toward inter-endothelial 
vascular junctions. Homophilic interactions with junctional molecules such as PECAM-1 
and JAMs results in junctional loosening, leukocyte extravasation and eventual basal 
lamina breach through gaps of low laminin expression217,230,231. Further proteolysis of the 
compact basal membrane surrounding the BBB by matrix metalloproteinases occurs to 
permit leukocyte entry into the parenchyma. 
 
5.1 Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE)  
 
In non-pathological conditions, BBB-ECs control the CNS microenvironment and 
limit the entrance of immune cells by expressing low levels of integrin ligands and 
activation markers, to achieve a precisely regulated biochemical and immunological 
homeostasis essential for reliable CNS function.  Immune cell infiltration and BBB 
breakdown is associated with many CNS diseases, including Alzheimer’s disease232, 
HIV-1-associated encephalomyelitis233, stroke234, amyotrophic lateral sclerosis235  and 
especially, MS79,223. MS is an inflammatory and demyelinating disease of the CNS 
characterized by multifocal perivascular immune infiltration, leading to demyelination 
and astrogliosis (astroglia activation and proliferation)236.  
CD4+ T cells, also called T helper (Th) cells, are a part of the adaptive immune 
system which generally recognizes foreign peptides, or antigens, and subsets of Th cells 
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are generally distinguished by their cytokine secretion profile. Th1 associated soluble 
mediators, interferon (IFN)-γ and tumor necrosis factor (TNF)-α, are pro-inflammatory 
cytokines and MS has been considered to be initiated by auto-reactive CD4+ Th1 cells 
that migrate across the BBB to access the CNS237,238. In fact, MS is generally considered 
a CD4+ T cell-mediated inflammatory disease, based on the cellular composition and 
number of immune cells that infiltrate the brain and cerebrospinal fluid (CSF) and on data 
from the mouse model of MS, experimental autoimmune (allergic) encephalomyelitis 
(EAE). Th17 cells are another subset of Th cells which secrete IL-17 and IFN-γ and has 
often been implicated in autoimmune diseases as these cells are found to be in MS lesions 
and IL-17 deficient mice significantly suppress EAE disease scores239,240. Finally, Th2 
cells secrete anti-inflammatory cytokines such as IL-4 and interferon (IFN)-β, thereby 
downregulating and suppressing the effects of pro-inflammatory Th1 and 17 effects. In 
fact, IFN-β is currently used as a therapy for MS due to immunomodulatory abilities241.  
Oligodendrocytes are CNS-derived glial cells responsible for the myelination of 
neurons. In MS, oligodendrocytes are a central target of the attacks by the host immune 
system242,243. Autoreactive CD4+ T cells have been found to recognize protein 
components of the myelin sheathe, such as myelin oligodendrocyte glycoprotein (MOG), 
proteolipid protein (PLP) and myelin basic protein (MBP), and initiate thus local 
inflammation, axonal demyelination lesions, and plaque formation236. Leukocytes 
accumulate in these lesions, most notably in the perivascular space surrounding small 
blood vessels. Continuous chronic inflammation can lead to recruitment of additional 
immune cells, furthering demyelination, axonal injury and glial scaring. In EAE, the 
injection of defined myelin components, together with an immune stimulating adjuvant, 
into naïve susceptible animals leads to a predominantly CD4+ T cell-mediated 
autoimmune diseases that shares similarities with MS. Whilst EAE cannot be transferred 
by antibodies, passively transferring encephalitogenic myelin-specific T cells in 
susceptible rodent and strands also leads to the diseases244. This demonstrates that EAE, 
and possibly MS, are T cell mediated autoimmune diseases. However, in certain EAE 
models used, the infiltration is characterized by a predominant infiltration of mostly 
CD4+ T cells into the spinal cord and brain stem, which are significant differences 
between the rodent model and the human pathology245. However, to induce EAE, PTX is 
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given, which opens the BBB246,247. This suggests that EAE is a combination of at least 
two processes, autoreactive T cells, and BBB disruption.  
In MS lesioned areas, the BBB becomes compromised and leaky, allowing entry 
of serum proteins and cells into the CNS. Clinically, BBB breakdown can be visualized 
by magnetic resonance imaging using gadolinium as a tracer molecule for lesions. 
Gadolinium leakage into the CNS parenchyma serves as a reliable marker for disease 
activity as it indicates inflammatory processes, making it an essential detection and 
diagnosis tool248,249. Gadolinium leakage may even precede the appearance of new 
lesions, suggesting potential BBB deregulation pathologies prior to inflammatory 
processes250. Lesion development is characterized by BBB activation and disruption in 
TJs organization, ensuing in changes in EC permeability42,64. Activated ECs, containing 
increased number of vesicles, decreased density of mitochondria, and expressing higher 
levels of CAMs, are also present in MS plaques251,252, which correlated with the 
accumulation of serum proteins in these areas. Nonetheless, active cell recruitment across 
BBB-ECs seems to be an essential step in contributing to CNS inflammation and 
subsequent tissue injury and BBB breakdown. Activated, myelin-specific leukocytes are 
primed through signaling via high levels of integrins and chemokine receptors, promoting 
their entry into CNS parenchyma. In fact, neutralizing antibodies (Natalizumab) against a 
leukocyte integrin suppress leukocyte entry into the CNS through inhibition of integrin-
binding to its ligand on the BBB-EC253. 
Upon entry into the CNS, leukocytes induce molecular changes in the nervous 
tissue and initiate transient or even chronic inflammatory reactions. Inflammatory 
cytokines such as IL-1, TNF-α, and IFN-γ, increase CAM expression and chemokine 
secretion by BBB-ECs and further modulate their TJs expression and function, aiding in 
the recruitment and entrance of more leukocytes to the site. BBB-ECs thus become an 
important source of pro-inflammatory chemokines, cytokines239,254 and CAMs23,72. This 
is the basis for the inflammatory cascade that leads to the focal inflammation of BBB-
ECs and the recruitment and infiltration of additional immune cells. The infiltrated 
immune cells will subsequently secrete additional cytokines and chemokines that may 
further enhance CNS inflammation or promote a gradual resolution of the inflammation. 
CD4+ T cell-associated soluble mediators such as IFN-γ and TNF-α are found in elevated 
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levels in CSF, serum and lesions of MS patients255. TNF-α was previously shown to be a 
potent modulator of brain endothelium permeability and both upregulate expression of 
ICAM-1 and VCAM-1 on the surface of BBB-ECs and increase the expression of 
chemokines IL-8/CXCL8, MCP-1/CCL2 and IP-10/CXCL10 in CNS and non-CNS 
ECs223. Thus, in vitro, TNF-α and IFN-γ are often used to mimic inflammatory 
conditions.  
Preventing leukocyte infiltration into the CNS is an important therapeutic strategy 
for treating patients with MS. As mentioned above, exogenously administered antibodies 
can block the entrance of leukocytes. Neurons and glial cells also produce a large variety 
of anti-inflammatory cytokines and immune modulators and the balance between pro- 
and anti-inflammatory cytokines is crucial to limit the inflammatory reaction in the CNS.  
 
5.2 The Hh signaling pathway in injury and MS 
 
Recovery from injury involves molecular and cellular events that are reminiscent 
of those during development as tissue repair partially recapitulates morphogenesis. After 
compression injuries, Shh mRNA expression is increased prominently within 
oligodendrocytes, Schwann cells and regenerating axons256. Shh expression is correlated 
with the expression of the neurotrophic factor brain-derived neurotrophic factor (BDNF), 
suggesting that Shh plays a neuroprotective and survival role for motor neurons. Indeed, 
on cultured Schwann cells, Shh treatment upregulates Gli-1 in addition to BDNF mRNA. 
Increased Shh reactivity is also reported after neural injury and Shh may play a role in 
neuronal repair and oligodendrocyte maturation257.  
Strong Shh expression is described on BBB endothelium, astrocytes and 
hypertrophic astrocytes within demyelinated brain lesions in rats with EAE258, suggesting 
that the Hh signaling pathway may also play a role in astrocyte-endothelium interactions 
and BBB maintenance or repair. However, research on Shh and its involvement in MS 
and EAE has mostly focused on the fact that Shh is critical for oligodendrocyte 
maturation, a crucial step in their ability to myelinate axons. Mature oligodendrocytes in 
adult mammalian CNS are post-mitotic and unable to proliferate in response to injury259. 
 38
Nevertheless, abundant oligodendrocyte precursor cells (OPCs) exists in the white and 
grey matter of normal adult CNS and could potentially contribute to remyelination. OPCs 
have been observed in MS lesions, but for the most part, they remain quiescent and thus 
represent a target for therapies to reactivate their differentiation into mature 
oligodendrocytes in order to enhance remyelination in MS patients260. Indeed, 
upregulation of Shh is essential for oligodendrogenesis and OPC development, including 
induction, survival, proliferation and migration of oligodendrocytes261,262. In spinal cord 
contusion, OPC implantation and Shh treatment improved white matter sparing263. 
In the subventricular zone (SVZ), astrocytes act as multipotent stem cells and 
support the neural stem cells (NSCs) niche264. Upon astrocytic influence, NSCs are 
induced to mature into neural precursor cells that will restore mature populations of 
astrocytes, neurons and oligodendrocytes. Wang and co-workers showed that Shh is 
expressed in the SVZ and constitutively expressed at low levels in the spinal cord of adult 
naïve mice, where it colocalizes with glial-fibrillary acidic protein (GFAP), a marker for 
astrocytes265. Non-niche astrocytes also secrete Shh, which potentially correlates to the 
atypical injury-induced niches that are formed by perivascular and parenchymal astroglia 
and ECs during EAE, facilitating NSC migration, differentiation and integration266. Co-
cultures of astrocytes and NSCs induces the differentiation of the stem cells into neurons, 
oligodendrocytes and astrocytes, whereby addition of anti-Shh neutralizing antibody 
inhibited differentiation, suggesting that adult astrocytes can induce NSC differentiation 
and that this process is supported by Shh. In addition, Shh-treated NSCs accelerates 
further oligodendrocyte differentiation265. 
Upon stimulations such as inflammation or injury, Shh was seen to be upregulated 
in hypertrophic astroglia associated with GFAP expression in MS lesions compared with 
control.  However, activation of atypical or SVZ niches does not occur in MS. Potent 
inflammatory cytokines, such as IFN-γ, can increase Shh in astroglia but downregulate 
Gli-1 expression in NSCs, thus disrupting the program of Shh-induced NSC 
differentiation. The downregulation of Gli-1 signal in OPCs may contribute to the 
impairment of OPC maturation in EAE and MS265. Another possible rationale for the 
inability of OPC activation might be the lack of Shh-cleavage within the white matter of 
MS patients. The white matter fraction of brains of MS patients contains the unprocessed 
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45kDa Shh protein, but the cleaved, active form (19kDa) of Shh was either absent or 
greatly reduced, compared to brains from healthy subject controls or from patients with 
other neurological diseases such as Alzheimer’s and Huntington’s267.  
IFN-β is commonly used in the treatment of demyelinating diseases such as 
relapse-remitting MS, but its diverse actions are not yet fully understood, but thought to 
impact and modulate the immune system, therefore causing an alteration of autoimmune 
progression. In a mouse model of spontaneously acute demyelination (ND4), Shh is 
upregulated during the demyelination phase, and is further upregulated after treatment of 
IFN-β in combination with vitamin B12. Combination therapy induces OPC maturation 
via Shh upregulation268. Finally, Niaspan is another treatment improving neurological 
functional recovery in EAE mice through the stimulation of the Shh pathway. In vitro, 
Niaspan treatment increases proliferation of immature OPCs. While Shh and Gli-1 
mRNA and protein expression are significantly decreased in EAE spinal cord, their 
expression is increased in spinal cord of Niaspan treated mice. In vivo, Niaspan increases 
oligodendrocyte proliferation and neuronal regeneration269. However, Niaspan also 
caused a reduction in the number of vessels containing inflammatory cell infiltrates and a 
decrease of EAE scores, which is potentially associated with the beneficial effects of Shh 
on the BBB itself, although this subject has never been touched upon. 
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6.0 LIPID MEMBRANE MICRODOMAINS  
This section contains excerpts from a review article entitled “Functions of lipid raft 
membrane microdomains at the blood-brain barrier”270. 
 
Due to the restrictive nature of the BBB, the movement of nutrients, molecules 
and cells between the blood and the CNS requires interactions with plasma membrane 
proteins to signal and initiate transport across the BBB. The plasma membrane of 
eukaryotic cells is composed of a complex mixture of membrane proteins and lipid 
molecules, including glycerophospholipids, sterols and sphingolipids. 
Glycerophospholipids tend to adopt a mobile loosely-packed fluid phase while sterols 
and sphingolipids possess distinct biophysical properties and readily group tightly 
together in a more ordered state. The differential lipid packing abilities lead to phase 
separation and to the organization of sphingolipid- and cholesterol-rich membrane 
microdomains, commonly referred to as rafts271-274. Lipid-enriched membrane rafts are 
dynamic plasma membrane microdomains associated with membrane 
compartmentalization, actin rearrangements and plasma membrane receptor-mediated 
signaling events271,272,275,276.  Current data generated on lipid rafts strongly suggest that 
these microdomains are biologically important and form a functional unit in the plasma 
membranes of cells.  
A specialized subset of rafts known as caveolae, defined as small cave-like 
surface invaginations of 50-100 nm in diameter, have been shown to mediate vesicular 
transport and sophisticated cell signaling. Caveolin-1, the main protein component of 
these structures, functions as a scaffolding protein and as a possible cholesterol sensor, 
regulating raft polymerization and lipid trafficking277,278. Unlike lipid rafts, caveolae are 
not present in all cell types, but are found abundantly in ECs and aid in regulating 
numerous endothelial functions such as transcytosis, vascular permeability and 
angiogenesis, and can serve as docking sites for glycolipids and GPI-linked proteins, as 
well as various receptors and signaling molecules279.  
Experimental studies have demonstrated that membrane clusters of 
glycosphingolipids and sterols were insoluble in detergents at 4°C and form detergent 
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resistant membranes (DRMs) that can be isolated by ultracentrifugation in a sucrose 
gradient. These observations, and others, have led to the lipid raft hypothesis that defines 
lipid (or membrane) rafts as 10-200 nm heterogeneous and highly dynamic structures 
enriched in cholesterol and sphingolipids271,272. While most of these lipid raft isolation 
protocols280 have been performed using Triton X (TX)-100 at 4°C281, many other 
detergents have also been used to prepare DRMs, including Lubrol282, Brij-58,-96,-98283, 
NP40, CHAPS and octylglucoside280,284. Non-detergent fractionation methods have also 
been used to isolate membrane rafts, and likely reproduce more accurately the in vivo 
protein oligomerizations that occur in microdomains285,286. In addition, due to their 
similar biophysical properties, caveolae represent a subset of the DRM population and 
can be further purified using magnetic beads coupled to antibodies against caveolin-1287. 
As a result of various DRM isolation techniques, the lipid, cholesterol and protein 
compositions within DRMs can vary, giving rise to biophysically diverse rafts. However, 
the heterogeneity of the lipid rafts, in addition to being an outcome of detergent 
selectivity, may also represent the underlying diversity of lipid and protein compositions.  
A wide variety of proteins are targeted to lipid rafts, notably, but not exclusively, 
via fatty acylation (myristate and palmitate modifications) and 
glycosylphosphatidylinositol (GPI)-anchors. Small rafts may be stabilized to form larger 
platforms through protein-protein or protein-lipid interactions. The raft microdomains 
have thus been associated with a wide range of biological processes, including 
endocytosis, signal transduction288, apoptosis, cell polarization289, adhesion, migration, 
synaptic transmission and cytoskeleton tethering275. In addition, the existence of distinct 
lipid constituents within membrane microdomains is important for cellular polarization. 
Apically, the membrane is enriched in glycosphingolipids and sphingomyelin, favoring 
the targeting of GPI-anchored proteins. Conversely, proteins important for contacting 
neighboring cells and the underlying connective tissue are confined to the basolateral 
membrane, suggesting the presence, within individual cells, of functionally different 
membrane domains290. Segregation of functionally diverse microdomains is an attractive 
notion, allowing the clustering of molecules that serve similar purposes together in order 
to optimize efficient intra-cellular signaling. These observations also suggest that 
membrane rafts have an active role in asymmetric redistribution of membrane proteins 
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during cell migration. Compartmentalized lipid rafts have been described in leukocytes, 
and most research has focused on membrane raft function during lymphocyte 
migration289,291. In ECs, lipid membrane rafts also exist but their role and function are 
still not well defined.  
Although lipids rafts have been extensively studied in T cell activation and 
migration289,292, lipid-enriched membrane compartmentalization is an inherent property of 
BBB-ECs and allows for the apico-basal polarity of brain endothelium, temporal and 
spatial coordination of cell signaling events and actin remodeling. Junctional proteins, 
adhesion molecules and transporters can also physically locate into lipid raft membrane 
microdomains of human and mouse BBB-ECs, and their expression and localization is 
regulated by inflammatory and glial-derived factors. In addition, a proteomic study was 
done in order to identify possible novel candidate proteins or signaling pathways 
important in BBB functions.  
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PART I:  
HYPOTHESIS AND OBJECTIVES 
 
Hypothesis 
 
In the light of the already acquired knowledge about the importance of lipid-enriched 
membrane microdomains in various cell types, I hypothesized that lipid rafts provide 
various functional platforms for effective protein interactions important in maintaining 
BBB properties. 
 
Objectives:  
 
1) To identify proteins expressed and/or enriched in human BBB-EC lipid 
membrane rafts and to propose a classification of endothelial membrane lipid raft 
based on their BBB-associated function, or at least on the function ascribed to the 
molecules included in such heterogeneous rafts. Data presented in Part I has been 
extracted from a review, on the functions of lipid membrane rafts in the BBB270, 
of which I am first author. 
 
2) To uncover novel proteins important in BBB-ECs, a liquid chromatography-mass 
spectrometry (LC-MSpect) proteomic analysis of rafts obtained from primary 
cultures of human BBB endothelium gave rise to a list of candidate proteins. My 
goal was to elucidate the function of novel proteins or possible signaling 
pathways necessary in preserving and upkeeping BBB characteristics. This set of 
data represents the basis of the study presented in Part II and a more detailed 
hypotheses and objectives specific to this aim will be described subsequently. 
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MATERIALS AND METHODS 
1.0 Detergent-resistant membrane (DRM) isolation and analysis  
 
BBB- EC isolation is described in Materials and methods of Part II. DRMs, or lipid 
membrane rafts, were isolated from confluent BBB-ECs using a previously published 
protocol23,43,293. Approximately 6 T75 flasks of BBB-ECs (per condition) were washed 
with ice cold PBS and scraped on ice. Following centrifugation, the pellets were 
resuspended in 1ml 1% of detergent in separation buffer (150mM NaCl, 25mMTris HCl 
pH7.4) with protease inhibitors (BD Biosciences, Franklin Lakes, NJ) and cells were 
solubilized for 30min on ice. Detergents used included Tween 20, Tween 80, Brij 58 and 
Brij98 (all from Sigma, Oakville, Ontario, Canada). The cell lysates were transferred to a 
glass homogenizer, dounced with 10 strokes of a loose fitting pestle and mixed with 1ml 
of 85% sucrose (Sigma) in separation buffer (w/v). The resulting 42.5% sucrose cell 
lysate was overlaid with 6ml 35% sucrose and 4ml 5% sucrose (w/v in separation buffer) 
and centrifuged for 24h at 39 000rpm at 4˚C in a Beckman SW41 rotor. Twelve 1ml 
fractions were collected at the meniscus, top to bottom, and the 4-5 fractions contained 
the DRMs, while the bottom fraction (10-12) were the soluble membrane fractions. 
Cholesterol, phospholipid and protein concentrations in each fraction were assayed using 
commercially available kits: Amplex red cholesterol assay kit (Molecular Probes, 
Eugene, OR), Phospholipids B Enzymatic colorimetric method kit (Wako, Richmond, 
VA) and BCA Protein assay kit (Pierce, Rockford, IL).  
 
1.1 Western blot of lipid membrane rafts 
 
For western blot (WB) analysis of lipid rafts, 40μg of each fraction were analyzed by 
standard SDS-PAGE using the following antibodies (Abs): mouse anti-JAM-A (1/500, 
BD Biosciences), rabbit anti-occludin (1/100, Zymed, South San Francisco, CA), rabbit 
anti-ZO-1 (1/100, Zymed), mouse anti-integrin α5 (1/5000), β1 (1/2500), αv (1/250) β3 
(1/2500, all integrin Abs from BD Biosciences), mouse anti-ICAM-1 (1/,500, BD 
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Biosciences), rabbit anti-ALCAM (1/200 Santa Cruz Biotechnology, Santa Cruz, CA), 
and mouse anti-MCAM (1/200, Miltenyi Biotec, Auburn, CA). Lipid raft markers were 
also assessed by SDS-PAGE using GM-1 cholera toxin B subunit, (1/10000, Molecular 
Probes); goat anti-CD59 (1/200, R&D Systems), and rabbit anti-caveolin-1 (1/200, Santa 
Cruz Biotechnology). Specific binding was revealed with horseradish peroxidase (HRP)-
conjugated anti-rabbit Ab using the ECL system (Amersham Biosciences, Piscataway, 
NJ). 
 
1.2 BBB-ECs lipid membrane raft proteomic analysis 
 
The isolated DRMs were dialyzed against denaturing buffer (50mM Tris-HCl, pH 8.5, 
0.1% SDS) and precipitated with 10 volumes of ice cold acetone. The precipitated 
proteins were resuspended in denaturing buffer and reduced and alkylated using 
dithiothrietol (4mM, 10min at 95°C), followed by iodoacetamide (10mM, 20min at RT). 
The proteins were trypsin-digested using 5 µg of trypsin gold (12-18h at 37°C, Promega, 
Madison, WI) and the resulting peptides were purified on CE column (POROS® 50 HS, 
50-µm particle size, 4.0mm ×15mm, Applied Biosystems, Forster City, CA) following 
the manufacturer’s protocol. The samples were then analyzed by tandem mass 
spectrometry on a hybrid quadrupole time-of-flight Q-TOF™ Ultima instrument (Waters, 
Milford, MA) with an electrospray ionization source and an online reverse phase liquid 
chromatography column (LC; PepMap C18 capillary column, Dionex/LC-Packings, 
Sunnyvale CA).  Peptides were separated on the LC column using a gradient of 5–75% 
acetonitrile, 0.2% formic acid in at least 90min, 350 nL/min supplied by a CapLC HPLC 
pump (Waters).  At least one 40min blank was ran in-between samples to prevent cross-
contaminations. MSpect/MSpect spectra were acquired in the auto-MSpect/MSpect mode 
(data-dependent scanning) on 2+, 3+, and 4+ ions. These were then submitted to a 
probability-based search engine, Mascot version 2.1.0 (Matrix Science Ltd., London, 
UK) to search against the NCBI's non-redundant human protein database. Searches were 
performed with a specified trypsin enzymatic cleavage with two possible missed 
cleavages and variable modifications for oxidation at methionine (+16 Da) and 
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carbamidomethyl at cysteine (+57 Da). The MSpect/MSpect spectrum of each identified 
peptide was manually examined and confirmed. 
RESULTS 
1.0 DRMs can be isolated from BBB-ECs 
The role of membrane microdomains in ECs has only recently been recognized as an 
important part of many vascular processes. Isolation of lipid rafts from human primary 
cultures of BBB-ECs has been performed using different techniques and detergents43,286. 
In Figure iii, different raft isolation preparations using four distinct mild detergents are 
shown to express variability, especially with regard to the concentration of cholesterol, 
caveolin-1 and GM-1, all markers used to identify rafts. Using these protocols, BBB-EC-
derived DRMs are enriched in caveolin-1 and also incorporate TJ proteins, integrins, 
specific transporters and CAMs. For example, in Figure iii, JAM-A, a transmembrane TJ 
protein associates with isolated membrane lipid rafts of BBB-ECs. Brij-58 enables a 
higher yield of lipid raft markers along with JAM-A expression, thus this detergent was 
used for the ensuing experiments. As lipid membrane rafts associate with functionally 
important BBB components, I thus propose to categorize BBB-EC lipid rafts based on the 
function of molecules found in these membrane compartments: 1) rafts associated with 
inter-endothelial TJ formation and EC adhesion to the basal lamina; 2) rafts involved in 
immune cell adhesion and recruitment across EC barriers and 3) rafts associated with 
transendothelial transport activity. A final category of molecules usually associated with 
neural process gave rise to further investigations on neural cues in the BBB (see Part II).   
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Figure iii: Use of different detergents to isolate cholesterol-enriched microdomains from 
human primary cultures of BBB-ECs. Four detergents were used to optimize cholesterol-
enriched DRM isolation from primary cultures of human BBB-ECs. Following treatment 
of the cells with the detergent, membrane microdomains were separated by sucrose-
density centrifugation. Cholesterol and phospholipid concentrations, as well as GM-1, 
caveolin-1, CD59 were used to identify raft fractions by Western blot. JAM-A is shown as 
an example of a TJ protein expressed in the raft fraction and its modulation according to 
the detergent used. 
Figure iii 47
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1.1 BBB-EC lipid membrane rafts contain junctional and integrin proteins  
In order to maintain a stable and tight functional barrier, lipid membrane rafts 
could potentially serve to regulate integrin-mediated attachment to the basal lamina, as 
well as TJ- and AJ-mediated cell-cell association8,210,214. Both AJs and TJs are important 
for the regulation of paracellular permeability of ions, solutes and nutrients and both 
junctional complexes localize, at least in part to membrane rafts293. Figure ivA shows 
examples of TJ proteins found in membrane rafts of human primary cultures of BBB-
ECs, isolated using Brij-58 and sucrose gradient centrifugation. The integral proteins 
occludin and JAM-A and the accessory protein ZO-1 were all found in DRMs, alongside 
caveolin-1, suggesting that lipid rafts can accommodate interacting transmembrane and 
cytosolic proteins. 
The endothelial basement membrane formed by BBB-ECs and perivascular 
astrocyte end feet are composed of several ECM components, including fibronectin, 
different laminin isoforms, collagen type IV and heparan sulfate proteoglycans209-211. Its 
dense and compact nature provides the ability to function as a substrate for soluble 
protein immobilization and cell attachment. BBB-ECs constitutively express a number of 
integrins important for adhesion to the endothelial basal lamina, such as α1β1, α3β1 and 
α6β1. In that respect, although the significance of lipid raft associated integrins remains to 
be established, my data presented in Figure ivB suggest that Brij-58-derived lipid rafts 
from human BBB-ECs also contain integrin proteins, such as α5, αv and β1, but not β3 
integrins, suggesting integrin specificity. This confirms that distinct BBB-EC membrane 
rafts are involved in the clustering of TJ, AJ and specific integrins, which collectively 
mediate attachment of ECs to adjacent cells and to the vessel wall. 
1.2 BBB-EC lipid membrane rafts contain adhesion molecules 
Under physiological conditions, only low number of immune cells continuously 
cross the BBB and enter the CNS perivascular space in a process called immune 
surveillance. This process is highly regulated in both leukocytes and ECs and lipid 
membrane rafts have been associated with leukocyte recruitment across the 
endothelium218,219.  
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Leukocyte rolling is dependent on CAMs and their respective carbohydrate 
ligands. In fact, CAM association with lipid membrane rafts is important for CAM-
dependent intracellular signaling216,294 and  lipid rafts can influence leukocyte-ECs 
interactions. Lymphocyte and myeloid cell diapedesis across CNS endothelium involves 
prototypic BBB CAMs such as ICAM-1 and ICAM-2 (for lymphocytes295 and VCAM-1 
(for myeloid cells)296,297  which are expressed on the cell surface and/or at intercellular 
junctions. These CAMs have been shown to associate with membrane 
microdomains217,226,228. In Figure ivC, I provide evidence that various CAMs can be 
expressed in lipid rafts. A large portion of total ICAM-1 can be found in BBB-EC DRMs. 
Novel CAMs recently associated with leukocyte transmigration, ALCAM and melanoma 
CAM (MCAM) were also found to be expressed in DRMs, suggesting that lipid 
membrane rafts are functionally important in regrouping CAMs for BBB-related 
purposes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure iv: Representative Western blots of isolated lipid rafts probed for scaffolding, TJ proteins and adhesion molecules.
Lipid raft were generated with treatment of primary cultures of human BBB-ECs with Brij 58 detergent followed by sucrose 
gradient centrifugation. Representative raft fraction (R) and detergent soluble fraction (S) were used to assess the presence of
TJ, integrins and adhesion molecules. A. The TJ proteins ZO-1, occludin and JAM-A are present in the lipid raft fraction, in 
addition to caveolin-1. B. Integrins α5 and β1 are readily detected in BBB-EC lipid rafts. Integrin αv is seen at lower levels 
and integrin β3 does not seem to be associated with lipid raft under physiological conditions. C. The cell adhesion molecules 
ICAM-1, ALCAM and MCAM can be detected in lipid raft fractions of BBB-ECs under normal culture conditions. 
A
A. B. C.
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1.3 BBB-EC lipid membrane rafts contain transporter proteins 
Transport of nutrients to the CNS is regulated by the expression of specific 
transporters in BBB-ECs. Expression of active transport systems for glucose, amino 
acids, nucleosides, fatty acids, minerals, vitamins, peptides, proteins and ions define the 
prototypic nature and function of the BBB. In our LC-Mspect analysis of rafts obtained 
from primary cultures of human BBB-ECs, several members of the transporter system 
were identified. Due to the expected high number of false-negative data generated by 
Mspect, this list can only be considered partial or incomplete, but includes many different 
transporter systems such as ion channels and lipid and fatty acid transporters (Table i). 
These findings indicate that rafts might also play an active role in trans-BBB trafficking 
of numerous lipid soluble and insoluble molecules.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GGTLA1, MGAT2, UGT2B11, B4GalNac-
T3, THUMPD2, MAT1A
Glycosyl, acetyl, methyl or nucleoside 
transferases
ApoB, ABCA6, PITPNM2, ABCA1Lipid and fatty acid transporters
SLC2A6, SLC45A4, SLC2A14Carbohydrate transporters
ABCA6, ABCB7 and ABCA1ABC transporters
SLC12A6, SLC4A3, SLC35E1, SLC41A2, 
HCN2
Potassium/chloride solute carrier family
ATP2B4Calcium transporting ATPase
CACNA2D1Voltage dependant calcium channel
SCNN1ANon voltage-gated sodium channel
GRIN2BGlutamate receptor
VDAC1, VDAC3Anion/cation transporters
Lipid raft associated transporterTransport System
Table i: Membrane raft microdomain associated transporters identified by proteomic 
analysis Human primary cultures of BBB-ECs were grown to confluence, lysed in Brij58 
detergent and cholesterol enriched membrane microdomains were isolated by sucrose 
gradient flotation. The raft fraction was subjected to trypsin digestion, separated by 
liquid chromatography and analyzed by LC-MSpect.
Table i 52
 53
1.4 BBB-EC lipid membrane rafts contain proteins typically associated with the 
nervous system 
 
In the last set of experiment and in an attempt to identify new proteins expressed in BBB 
lipid membrane rafts, lipid membrane rafts were isolated from monolayers of human 
BBB-ECs using the detergent Brij-58 and were sent for proteomic analysis by nanoflow 
LC-tandem Mspect (as described previously). This analysis confirmed the presence of 
proteins involved in cell-cell adhesion processes (18%), intracellular trafficking and 
cytoskeleton remodeling (30%) as BBB-EC lipid rafts are highly involved in cell 
adherence and transport properties. According to the nature of the BBB, proteins 
involved in lipid, protein and carbohydrate metabolism (20%) as well as signal 
transduction proteins (15%) and proteins of unknown function (6%) were also found 
(Figure v). Surprisingly, amongst the candidates found in the proteomic screen were 
proteins well known for their role in nervous system development and neuronal synapse 
function (11%). For example, slit-1 is a ligand for its receptor Roundabout (Robo) and is 
primarily known to act as a neural guidance cue for commissural neurons crossing the 
floor plate during embryonic development and recent reports have associated this 
pathway to angiogenic processes120,125. FAT tumor suppressor and Dachsous are atypical 
cadherins that mediate planar cell polarity and tissue morphogenesis298. Similarly, 
Hedgehog-interacting protein (Hip) is part of the Hedgehog (Hh) signaling pathway, a 
pathway important in tissue morphogenesis, neural development, axon guidance, and 
angiogenesis147,155. Nerve growth factor (NGF) receptor is critical for survival and 
maintenance of neurons299. As for the rest of proteins included in the candidate list, the 
stomatins, RIM-binding protein-2, GABA transporter, contactin 4 (also know as axonal 
CAM, or AXCAM), 43kDa receptor associated protein of the synapse and NMDA 
receptor precursor, all are expressed pre or post-synaptically300-303. Of these novel 
candidates and their associated pathways, I selected to study the importance of the Hh 
signaling pathway at the level of the BBB for Part II of my project. 
 
 
 
Intracellular trafficking and 
cytoskeleton remodelling, 30%
Protein, lipid and carbohydrate
Metabolism, 20%
Unknown
function, 6%
Neuronal and synapse 
associated proteins, 11%
Signal transduction, 15%
Cell adhesion, 18%
• N-methyl-D-aspartate receptor 
subunit 2B precursor
• contactin 4 isoform a precursor
• 43kD receptor-associated protein of 
the synapse isoform 1
• hedgehog-interacting protein
• GABA/noradrenaline transporter
• FAT tumor suppressor 2   
precursor
• dachsous 1 precursor
• slit homolog 1
• RIM-binding protein 2
• Nerve growth factor receptor 
precursor 
• stomatin-like 3
Neuronal and synapse 
associated proteins, 11%
Figure v: BBB-EC DRM isolation and 
proteomic analysis A. Pie chart classification 
of the DRM-associated proteins identified by 
nanoflow LC-tandem MSpect. BBB-EC DRMs 
are mainly composed of signal transduction 
molecules (15%) with some associated 
cytoskeleton proteins (30%) and proteins 
involved in protein, lipid and carbohydrate 
metabolism (20%). Additional proteins 
identified are cell-cell adhesion molecules 
(18%) and neuronal and synaptic associated 
proteins (11%). B. Representative list of BBB-
EC lipid DRM-associated proteins identified 
by nanoLC-MSpect which are typically found 
associated with nervous system processes such 
as in neural development or pre and/or post-
synaptic termini.
A.
B.
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PART II: 
HYPOTHESIS AND OBJECTIVES 
 
Preamble: 
 
As for now, the influence of astrocytes has been reported on BBB permeability and 
activation during immune reactions occurring within the CNS. However, the identity of 
the specific factors is still under investigation. The Hh pathway has been implicated in 
vasculogenesis and angiogenesis, but no function has yet been ascribed to the BBB 
directly.  
 
Hypothesis: 
 
I hypothesize that astrocyte-derived Shh contributes to the maintenance of BBB 
properties and functions. My aim is to identify the functional significance of the Hh 
pathway at the human BBB. To address this hypothesis, I propose the following specific 
aims: 
 
Objectives:  
 
1) To characterize the expression and cellular localization of Hh pathway proteins at 
the level of human astrocytes and BBB-ECs, both in vitro, in primary cultures of 
human astrocytes and BBB-ECs, and in situ, using normal human brain tissue 
sections. 
  
2) To study the role of the Hh pathway on the permeability of human BBB-ECs to 
soluble molecules in vitro and in vivo using available pharmalogical tools to 
stimulate or block the Hh pathway.  
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3) To determine the contribution of the Hh pathway in the generation and 
maintenance of TJ expression in BBB-ECs in vitro, using pharmacological tools 
and in vivo, using embryonic CNS tissue from Shh -/- mice.  
 
4) To identify the immune responses of the BBB-ECs upon Hh activation by 
investigating chemokine release, adhesion molecule surface expression, and BBB 
immune permeability in vitro. 
 
5) To examine the expression of Hh pathway components in relation to 
inflammation in vitro, in the context of the inflammatory cytokines TNF-α and 
IFN-γ, and in situ with immunostainings of human brain tissue sections from MS 
patients. To assess differences in expression of Hh pathway proteins, lesions and 
normal appearing white matter will be compared. 
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Abstract 
During embryogenesis, vascular development is characterized by sequential steps of 
vasculogenesis, angiogenesis, and in some organs, barriergenesis. In the CNS, the blood-
brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) which regulate 
the entry of blood-borne molecules and immune cells into the CNS. Perivascular 
astrocytes are known to regulate BBB permeability and quiescence by secreting essential 
factors, the identity of which remains unclear. Our study shows that human astrocytes 
express and secrete Sonic Hh (Shh) and conversely, that human BBB-ECs bear the Hh 
receptor Patched-1 (Ptch-1), the signal transducer Smoothened (Smo) as well as 
transcription factors of the Gli family. Furthermore, we show that activation of the Hh 
pathway in BBB-ECs restricts the passage of soluble tracers in vitro and in vivo. 
Blocking Hh signaling in vitro and using Shh knock-out (-/-) embryonic mice, we 
demonstrate a reduced expression of TJ molecules claudin-5, occludin and ZO-1. Hh 
activation also decreases the surface expression of cell adhesion molecules ICAM-1 and 
VCAM-1, and decreases BBB-ECs secretion of pro-inflammatory cytokines IL-8/CXCL8 
and monocytes chemoattractant protein 1 MCP-1/CCL2, resulting in a reduction of 
migrating CD4+ lymphocytes across human BBB-EC monolayers. In vitro treatment with 
inflammatory cytokines TNF-α and IFN-γ, upregulates the production of astrocytic Shh 
and the BBB-EC surface expression of Ptch-1 and Smo. In active Multiple Sclerosis 
(MS) lesions, in which the BBB is disrupted, Shh expression is drastically upregulated in 
hypertrophic astrocytes, while Ptch-1 and Smo expression is down-regulated or left 
unchanged, suggesting that a deregulation in the Hh signaling pathway may prevent the 
barrier stabilizing properties of Hh. Our data demonstrate an anti-inflammatory and BBB-
promoting effect of astrocyte-secreted Hh and suggest that a pro-inflammatory 
environment disrupt the BBB by impacting, at least in part, on Hh signaling in brain ECs. 
 
Key words: Blood-brain barrier, tight junction, Sonic Hedgehog, astrocyte, endothelial, 
endothelium, permeability, chemokine, cell adhesion molecule, inflammation, Multiple 
Sclerosis 
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Introduction 
The blood-brain barrier (BBB) protects the central nervous system (CNS) from 
blood-borne molecules and circulating immune cells. The BBB is composed of 
specialized endothelial cells (ECs) held together through multiprotein complexes known 
as tight junctions (TJ)11,27,270. Astrocytes, which are in close apposition to the cerebral 
vasculature, help maintain BBB integrity and immune quiescence through contact 
dependant support mechanisms and the release of essential soluble factors11,24,304. In the 
course of multiple sclerosis (MS), a breakdown in the BBB occurs, allowing auto-
reactive immune cells to enter the brain parenchyma causing demyelination and neuronal 
damage21,79,223. The current view is that astrocytes are key regulators of BBB 
development, maintenance and regulation and that understanding the complex astrocyte-
EC interactions under physiological and pathological conditions may lead to the 
development of novel therapeutic strategies. 
The hedgehog (Hh) pathway is a conserved signaling cascade involved in 
embryonic morphogenesis, pathfinding, and as recent studies show, angiogenesis130,147. In 
adult tissues, it plays an important role in vascular proliferation, differentiation and tissue 
repair7,182,193. Hh signaling is initiated by one of three secreted homologues of the 
Drosophila Hh; Indian Hh (Ihh), Desert Hh (Dhh) and Sonic Hh (Shh). Shh is the most 
studied of these ligands has been widely associated with morphogenic events such as 
posterior identity of the limb bud150, ventral cell identity of the neural tube, and motor 
neuron development151,152. Essential to Hh signaling is the internal autocatalytic cleavage 
of the 45kDa protein to yield the ~19kDa N-terminal signaling domain. Following the 
post-translational addition of cholesterol and palmitoyl moieties, Shh is released from the 
producing cell and binds with high affinity to the cell surface receptor Patched (Ptch-1)-1, 
a 12-transmembrane domain receptor. Engagement of Ptch-1 alleviates repression of the 
signal transducer Smoothened (Smo), a serpentine protein with a topology reminiscent of 
Frizzled family of Wnt receptors and other G-protein coupled receptors146,158. Once Smo 
is in its active state, activation of zinc-finger transcription factors of the Gli family (Gli1-
3) act at the last step of the Shh-signal-transduction pathway. In addition to the influence 
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of specific factors on the response of a cell to the Hh signal received, proteins of the Hh 
cascade itself, such as Ptch-1 and Gli-1 are upregulated149. 
Members of the Wnt, Hedgehog (Hh), fibroblast growth factor (FGF) and bone 
morphogenic protein (BMP) families were shown to act as classical morphogens in a 
number of different contexts116,117. FGF103, BMP140 and Wnt141,142,144 signaling pathways 
have been reported to act on cerebral vascular development and on the formation of a 
mature BBB. Prior studies have demonstrated strong Shh expression on BBB 
endothelium, astrocytes and hypertrophic astrocytes within demyelinated and 
remyelinating brain lesions in rats with experimental autoimmune encephalomyelitis 
(EAE)258, suggesting that the Hh signaling pathway may play a role in astrocyte-
endothelium interactions and BBB maintenance or repair. However, research on Shh and 
its involvement in MS and EAE has mostly focused on the fact that Shh is critical for 
oligodendrocyte maturation263, a crucial step in their ability to myelinate axons. Wang 
and coworkers described astrocyte upregulation during MS inflammation, where Gli-1 
was paradoxically decreased in oligodendrocyte progenitor cells in chronic inflammatory 
lesions, proposing that failure to remyelinate may be due compromised Hh pathway in 
myelinating oligodendrocytes265.  
In the peripheral nervous system (PNS), Dhh is needed for the formation and 
maintenance of the perineurium, a component of the blood-nerve barrier that acts as a 
barrier against blood borne molecules and cellular infiltration206. Therefore, the Hh 
pathway seems to be involved in the formation of and ordered and functionally 
competent perineurium, seen as a later stage of perineurial sheath maturation. By 
analogy, these studies raise the question of whether the Hh pathway plays a role in other 
barrier contexts, such as the BBB. In the current study, we demonstrate that astrocyte 
secreted Shh impact on BBB-ECs and that the activation of the Hh signaling cascade 
contributes to the maintenance of BBB functions.  
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Results 
Astrocyte and blood-brain barrier endothelial cell expression of hedgehog pathway 
components 
Reverse transcription - polymerase chain reaction (RT-PCR) was performed using 
primers specific for human Sonic Hedgehog (Shh), Pactched-1 (Ptch-1) and Smoothened 
(Smo). As seen in Figure 1A, two separate preparations of primary cultures of human 
fetal astrocytes (HFA) express Shh mRNA. Human adult blood-brain barrier (BBB) 
endothelial cells (ECs) did not express Shh (30 PCR cycles). Expression of Ptch-1, and 
Smo mRNA was observed at low levels in HFAs, and higher levels were detected in 
BBB-ECs. Assessment of protein production by Western Blot (WB) revealed that whole 
cell lysates of primary cultures of HFAs contain the uncleaved precursor form of Shh 
protein at 45kDa (Figure 1B). However, to ascertain that HFAs have the capacity to 
secrete the active cleaved form of Shh (at 19KDa, 170108 antibody recognizes both 
cleaved and uncleaved forms), astrocyte conditioned media (ACM) was precipitated and 
blotted for Shh. ACM collected after one week of conditioning was found to contain the 
cleaved form of Shh (19kDa, Figure 1B, right panel), and it was detected at the same 
molecular weight as the human recombinant Shh (hrShh) peptide. While human adult 
BBB-ECs did not express Shh, Ptch-1 expression on these cells was confirmed (Figure 
1B, left panel). Immunocytofluorescence analysis further confirmed intracellular 
astrocytic Shh immunosignal (Figure 1C). As shown, HFAs positive for Shh expressed 
GFAP, confirming that the source of Shh in these cultures was indeed the astrocytes and 
not possible contaminating neurons. Membrane-bound Ptch-1 and Smo were also 
detected on BBB-ECs (Figure 1C). Immunohistochemistry analysis of these Hh 
components was further performed on frozen control human adult brain sections. 
Determined by their morphology and location, perivascular astrocytes were seen to be 
most immunopositive for Shh (arrowheads, Figure 1D), with the strongest staining seen 
at the boundary of the blood vessels. Higher magnification of perivascular astrocyte 
(arrowhead) demonstrates Shh expression in the cell body and endfeet (arrows) opposing 
parenchymal vessel (asterisk). This confirms previous work that suggested Shh 
immunoreactivity in astrocytes258,265. Ptch-1 and Smo were strongly expressed in BBB-
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ECs (Figure 1D). Thus, human astrocytes express and secrete Shh, in vitro and in situ and 
brain endothelium, on the other hand, expresses Ptch-1 and Smo, supporting the 
possibility that the Hh pathway is used for communication between perivascular 
astrocytes and BBB-ECs.  
Astrocyte-secreted sonic hedgehog decreases permeability in vitro 
Shh was previously shown to induce in vitro capillary morphogenesis in mouse 
brain-derived EC lines, bEnd.3 and IBE4,182. Primary cultures of confluent human BBB-
EC monolayers in vitro form a semi-permeable barrier which restricts diffusion of soluble 
tracers. We and others have previously demonstrated that astrocyte-derived soluble 
factors present in the ACM decrease BBB-EC permeability to soluble tracers43,68. In a 
modified Boyden chamber permeability assay using human BBB-ECs, 40% ACM (v/v) 
induced an important decrease in permeability to the large molecular weight tracer 
Fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA) (Figure 2A). This 
effect was long lasting, as evidenced by the important difference in tracer diffusion up to 
72h (n=8 independent experiments, in duplicate, *p<0.05). Addition of hrShh (0.1μg/ml) 
to BBB-ECs 24h prior to tracer addition reproduced the effect of ACM (Figure 2A, n=8, 
*p<0.05). The concentration used reflects the lowest concentration required by 
endothelial precursor cells to induce migration and vascular-endothelial growth factor 
(VEGF) production305. In our experiment, BBB-ECs responded to hrShh in a dose-
dependent fashion, as permeability decreased with increasing hrShh concentrations, and 
did not affect EC proliferation (Supplementary Figure 1). To assess whether activation of 
the Hh pathway was responsible for the BBB-EC barrier promoting effects of ACM, 
BBB-ECs were treated with Smo non-peptide receptor agonist purmorphamine (100nM) 
or antagonist cyclopamine (30μM). Treatment with the Smo agonist (purmorphamine) 
reproduced the effect of hrShh on BBB-ECs (Figure 2B, n=8, *p<0.05). However, Smo 
antagonist (cyclopamine) treatment of BBB-ECs grown in ACM reversed the barrier 
promoting effects of the ACM, resulting in an increase of the permeability of BBB-ECs 
that compared to the levels of untreated ECs (Figure 2C, n=6). Another Smo antagonist, 
SANT-1, also abrogated the effect of ACM on permeability (data not shown), suggesting 
that Smo is important in the EC barrier properties. Treatment with Smo antagonists alone 
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had no effect on the permeability or proliferation of the BBB-ECs as compared to control 
treatments (data not shown). In separate experiments, similar decreases in permeability, 
using hrShh and Smo agonist, were obtained with the small molecular weight tracer 14C-
sucrose (Supplementary Figure 1). Thus, our data demonstrates that astrocyte-produced 
Shh promotes barrier properties in human BBB-ECs through activation of the Hh signal 
transducer Smo. 
 
Cyclopamine induces BBB disruption in vivo 
To confirm the role of the Hh pathway in BBB maintenance, we studied the 
extent of BBB leakage in 7-8 week old c57Bl/6 mice injected with 10mg/kg of 
cyclopamine or equal volume of vehicle (Hydroxypropyl-β-cyclodextrin, HPBCD). The 
extent of BBB disruption was determined by extravasation of the 70kDa exogenous 
soluble tracer Dextran-FITC, as well as by the endogenous plasma protein fibrinogen, a 
molecule that does not cross the BBB in normal conditions. Using confocal microscopy 
and fluorescent quantification imaging techniques, we found that cyclopamine-injected 
mice displayed a significant increase in the area and peak fluorescence intensity of 
Dextran-FITC and fibrinogen (4.49x105 ± 1.38x105 and 1.36x106 ± 4.19x105, 
respectively; n=12 vessels) in both small and large vessels, as compared to counterparts 
from vehicle treated mice (3.27x104 ± 1.02x104 and 1.98x105 ± 8.25x104, n=9 vessels; 
*p<0.05) (Figure 2D). Representative images taken of Dextran-FITC and fibrinogen 
immunostaining demonstrate leakage (arrowheads) 6h after cyclopamine treatment, while 
in vehicle treated mice, these tracers remained in the lumen of the vessels (Figure 2E). 
Our results demonstrate that in mice treated with the Smo antagonist cyclopamine, BBB 
leakage occurs with molecules of molecular sizes of 70 and 340 kDa, leaking from the 
blood into the parenchyma. Thus, the Hh pathway is important in the maintenance of 
adult mouse BBB function and disruption of this pathway leads to, at least, acute BBB 
breakdown in vivo. 
Sonic hedgehog promote and maintain tight junction protein expression 
Parmentier and colleagues have shown that formation of the blood-nerve barrier 
made by the perineurium and the nerve bundle endothelial cells206,306, depends on 
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Schwann cell-derived Dhh signal. We tested whether expression of endothelial TJs in 
human BBB-ECs depended on astrocyte-derived Shh signal. Quantitative real-time PCR 
of human BBB-ECs shows an upregulation of Ptch-1 mRNA expression when cells are 
grown with ACM or treated with hrShh (0.1μg/ml, 24h, Figure 3A), confirming Hh 
activation in either case. In addition, occludin and claudin-5 mRNA expressions by 
human BBB-ECs were upregulated with ACM and hrShh (Figure 3A). WB analysis of 
protein expression demonstrates that ACM increases claudin-5, occludin, and JAM-A 
expression in whole cell lysates of BBB-ECs (Figure 3B). However, when the Hh 
pathway is antagonized by cyclopamine treatment, expression of claudin-5, occludin and 
JAM-A expression decreases to 21.3%, 77.9%, and 31.3%, respectively, compared to 
ACM-grown astrocytes (Figure 3B).  
The generation of Shh deficient mice has been previously described150. Shh 
knock-out (-/-) mice have an overall reduction in size from their wildtype (WT) 
littermates, and because of early embryonic lethality, embryos need to be harvested 
between E11 and E13.5. The development of the BBB occurs gradually, as disappearance 
of fenestration and appearance of TJs in the endothelium occurs between embryonic 
stages E11 and E13307 such that by E12, the CNS has already become impermeable to 
trypan blue and HRP tracers308. Brain sections from E13.5 WT and Shh-/- mice were thus 
immunostained for TJ protein claudin-5, occludin, and ZO-1. FITC-conjugated 
Lycopersicon Esculentum (Tomato) lectin was used to provide a frame of reference for 
the localization of the blood vessels. Although distinct TJ strands were visible in brain 
capillaries of both WT and Shh -/- brains (Figure 3C), the brains from Shh-/- had 
significantly fewer ECs immunopositive for specific TJ proteins (Figure 3C and corner 
insets displaying lectin-positive ECs). In WT brain, a relatively high percentage of lectin-
binding ECs were immunopositive for claudin-5 (79.2 ± 3.1), occludin (64.7 ± 6.4), and 
ZO-1 (87.8 ± 2.3). In contrast, the lectin positive cells of Shh -/- animals demonstrated a 
significant reduction in immunopositivity for claudin-5, (37.0 ± 2.6, ***p<0.0001) and 
ZO-1 (48.1 ± 6.0, ***p<0.0001), while occludin expression was nearly absent (8.1 ± 3.8, 
***p<0.0001) (Figure 3D). Peak fluorescence intensity was also measured, and the TJ 
strands of Shh-/- were significantly less intense than TJs from WT brains (data not 
shown).  Therefore, the data suggest that Shh secreted by astrocytes is important in the 
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induction and maintenance of TJ expression, and that loss of Shh signaling may 
contribute to loss of barrier function. 
 
Hedgehog activation influences cell adhesion molecule expression, cytokine secretion 
and lymphocyte migration 
ECs, in general, and BBB-ECs in particular, actively participate in the 
inflammatory reactions and can directly influence immune cell migration by regulating 
cell adhesion molecules (CAMs) expression as well as the secretion of cytokines and 
chemokines218,219,309. Under basal conditions, cultures of human adult primary BBB-ECs 
express intracellular cell adhesion molecule (ICAM)-1 and to lesser extent, vascular cell 
adhesion molecule (VCAM)-1 (73.9% and 3.4%, respectively, Figure 4A). When grown 
with 40% ACM (v/v), the levels of ICAM-1 and VCAM-1 decrease (63.9% and 1.7%), 
suggesting that astrocytic factors contribute to the immuno-quiescence of the barrier. On 
the other hand, when Hh pathway activation was impeded by the use of cyclopamine 
treatment (30μM, 24h), ICAM-1 and VCAM-1 levels remained at basal levels (72.7% 
and 3.6%). BBB-ECs treated with hrShh (0.1μg/ml, 24h) and purmorphamine (1uM, 24h) 
had decreased levels of ICAM-1 and VCAM-1 (66.6% and 2.8% for hrShh and 59.3% 
and 2.2% for purmorphamine), demonstrating that Shh is a potent anti-inflammatory 
signal decreasing the expression of CAMs at the surface of BBB-ECs. These findings 
were confirmed by calculating the mean fluorescent intensities (MFI) for ICAM-1 (n=3, 
*p<0.05, Figure 4B). Cytokine/chemokine secretion from BBB-ECs was also assessed, 
by ELISA, to further evaluate the role of Shh in BBB quiescence. Upon treatment with 
hrShh or purmorphamine, the secretion of both IL-8/CXCL8 and MCP-1/CCL2 
significantly decreased (Figure 4C, n=4, **p<0.005 and ***p<0.0005 respectively). Smo 
inactivation with cyclopamine, even in the presence of hrShh treatment, abrogates this 
effect. These observations suggest that Shh negatively influences the ability of BBB-ECs 
to chemoattract and recruit leukocytes. To address this possibility, the ability of 
leukocytes to transmigrate through Hh activated BBB-ECs was evaluated using the 
modified Boyden chamber assay. CD4+ T cell migration was significantly reduced in 
BBB-ECs grown with ACM, as well as BBB-ECs treated with hrShh and purmorphamine 
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(80%, 75% and 65% reduction in CD4+ lymphocyte transmigration compared to resting 
BBB-ECs, *p<0.05, **p<0.005, ***p<0.0005, respectively, Figure 4D). Furthermore, the 
transmigration of CD4+ lymphocyte across cyclopamine treated BBB-ECs did not differ 
from the migration of untreated BBB-ECs (Figure 4D). Collectively, these findings point 
to an endogenous, anti-inflammatory role of the Hh pathways at the level of the BBB, as 
Smo engagement reduces CAM expression, chemokine secretion and lymphocyte 
migration. 
 
Transcription factor upregulation upon hedgehog activation 
Upregulation of Gli-1 expression is generally used as an indicator of Hh 
activation146,147. Flow cytometry analysis of intracellular staining for Gli-1 was 
performed to determine the level of Hh activation in BBB-ECs. BBB-ECs treated with 
hrShh (24h, 0.1μg/ml) or with purmorphamine (24h, 1μM) showed increased expression 
of Gli-1 (45.3% and 65.4%, respectively), compared to untreated control, (26.7%, Figure 
5A). Similarly, BBB-ECs cultured in ACM increased the expression of Gli-1 (43.1%) 
compared to untreated control (26.7%). However, blocking the Hh cascade with 
cyclopamine reduced the expression of Gli-1 induced by ACM (34.8% compared to 
43.1% in ACM-grown BBB-ECs, Figure 5A). Mean fluorescent intensities for Gli-1 were 
also evaluated and confirmed the pattern of effect previously described (n=2, *p<0.05, 
**p<0.01, Figure 5B).  
Quantitative real-time PCR was used to determine the kinetics of BBB-EC Gli-1 
mRNA upregulation upon hrShh stimulation and to study the activation of transcription 
factors involved with BBB function. Sex-determining region Y-box (SOX)-18 is an 
endothelial-specific transcription factor that is important in regulating claudin-5 gene 
expression and EC barrier formation310.  Upregulation of Gli-1 mRNA in BBB-ECs 
occurs rapidly following hrShh stimulation (n=2, ***p<0.001 at 1h, **p<0.01 at 3h, 
Figure 5C). However, the expression of SOX-18 occurs 3h after hrShh stimulation (n=2, 
***p<0.001 at 3h, **p<0.0.1 at 6h, Figure 5C), suggesting not only that SOX-18 is 
regulated by the Hh pathway, but that Gli-1 may regulate SOX-18 expression in BBB-
ECs. 
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Pro-inflammatory cytokines modulates the hedgehog signaling pathway in vitro  
As neuroinflammatory conditions are associated with a BBB breakdown, we 
further evaluated the in vitro effects of the pro-inflammatory cytokines TNF-α and IFN-γ 
on Hh component expression. In primary cultures of HFAs, extracellular staining for 
major histocompatibility complex I (MHC I or HLA-ABC) and intracellular staining for 
GFAP differentiated the population of astrocytes from potentially contaminating neurons, 
which are both MHC I and GFAP negative (Figure 6A). In the astrocyte population 
(gated for MHC I+/GFAP+), expression of Shh substantially increases (63.4%) after 
treatment with both IFN-γ and TNF-α (100 U/ml each, 24h) compared to untreated 
control (44.5%, Figure 6A). MHC I is drastically increased upon inflammatory 
stimulation and was used as a marker for astrocytes, as it is rarely expressed by 
contaminating neurons311. Surface immunostaining for Ptch-1 and Smo on BBB-ECs 
grown in ACM (40%) revealed that treatment with inflammatory cytokines TNF-α and 
IFN-γ (100U/ml each, 24h) increased expression levels of both Ptch-1 (59.3%) and Smo 
(54.4%), compared to control levels (30.0% and 27.6% respectively; Figure 6B). These 
data suggest that upon inflammatory stimulation, astrocytes and BBB-ECs react by 
upregulating the anti-inflammatory Hh pathway members.   
 
Modulation of the hedgehog signaling pathway in situ in Multiple sclerosis 
Plaque formation and inflammatory cell infiltrations into brain tissue are hallmark 
signs of Multiple Sclerosis (MS). In control brain tissue and normal appearing white 
matter (NAWM), we observed pronounced Shh immunostaining in astrocytes (Figure 
7A). Interestingly, astrocyte processes and endfeet surrounding parenchymal vessels 
display Shh immunoreactivity (arrowheads; Figure 7B) that is strikingly enhanced in 
hypertrophic astrocyte cell bodies and processes throughout active demyelinating MS 
lesions (arrowheads; Figure 7C, n=6 lesions). Double immunofluorescent staining 
confirmed expression of Shh (green) in GFAP (red) positive perivascular astrocytes 
(arrowheads), as seen in the overlay pictures (Figure7D). 
Whereas in vitro cultures of BBB-ECs, derived from essentially healthy brain 
tissues, upregulated both Ptch-1 and Smo under inflammatory conditions (Figure 6), MS 
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brain BBB-ECs exhibited a different pattern of expression. In control NAWM tissue, 
Ptch-1 expression was mainly restricted to blood vessels (arrowheads; Figure 8A). In 
active MS lesions, while Ptch-1 and Smo immunostaining were predominantly observed 
in macrophages (arrows; Figure 8A and B), their level expression in brain ECs remained 
unchanged (arrowheads; Figure 8A and B). Double fluorescent staining revealed 
colocalization of Ptch-1 with Gli-1 in blood vessels of NAWM and active MS tissue 
(Figure 8C). No difference in expression levels of Ptch-1 and Gli-1 were observed in 
brain ECs, although Gli-1 immunoreactivity was detected in infiltrating leukocytes in the 
MS lesion. The expression pattern of Shh, Smo and Patched-1 in NAWM was similar to 
that observed in control brain tissue.  
 
Discussion 
 
In this study, we demonstrated that astrocyte-derived Shh acts on human BBB-
ECs to decrease permeability of the BBB to soluble factors in vitro and in vivo, a process 
that is Smo-dependent. This effect is driven by the ability of Shh to induce and maintain 
TJ protein expression through activation of Gli-1 and SOX-18. We further demonstrate 
that Shh regulates BBB-EC activation by lowering their expression of surface CAMs and 
secretion of pro-inflammatory chemokines. Consequently, a decrease in transmigrating 
lymphocytes across the BBB-EC monolayer was observed, suggesting that Shh acts as a 
direct negative regulator of CNS inflammation. In inflammatory contexts, an increase in 
Shh was observed when human astrocytes were cultured in the presence of inflammatory 
cytokines TNF-α and IFN-γ. Surface expression of both Ptch-1 and Smo were also 
increased in BBB-ECs treated with the same inflammatory cytokines. However, in MS 
plaques, while hypertrophic astrocytes upregulated Shh expression, ECs were not found 
to correspondingly increase the expression of the receptors, Ptch-1 and Smo.  
The anatomical proximity of the astrocytic endfeet to the CNS-ECs has lead to the 
notion that astrocytes impact on BBB properties. Astrocyte-derived soluble factors have 
been shown essential for the development and maintenance of an impermeable BBB as 
ACM induces junction formation and strong transendothelial electrical resistance in 
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either CNS or non-CNS-derived ECs, in vitro24,312,313. Morphogens have been linked to 
cooperate in astrocyte-endothelial interactions. Proteins of the FGF family were found to 
decrease the permeability of the BBB in vitro103. Similarly, conditioned media containing 
Wnt3a induces TJ strand formation, junctional protein expression and BBB-EC 
morphology142. Although human and mouse astrocytes have previously been shown to 
express Shh258,265, its impact on BBB function has not been studied. Our data clearly 
identifies the Hh signaling pathway as an important determinant of BBB function and 
maintenance. 
Shh has been involved in a multitude of developmental processes, ranging from 
embryonic tissue patterning, ventralization of neural tube, and establishment of posterior 
identity in the developing limb bud152,314. Others have found that Shh can induce capillary 
morphogenesis182, a process which requires promoting assembly via cell-cell contact. 
Evidence that Shh may be involved in maturation of endothelium can be seen in 
developing mouse models. In the developing mouse submandibular gland, lumen 
formation and TJ assembly occurs in the epithelial cell lining, processes dependent on 
Shh. Shh null mice had developmentally arrested submandibular gland epithelium, and 
treatment with Shh recovered and enhanced epithelial lumen formation, full cell 
polarization as well as epithelial TJ protein distribution205. In the PNS, Dhh is expressed 
in myelinating Schwann cell and is needed for the formation and maintenance of the 
perineurium, a component of the blood-nerve barrier. Dhh -/- animals have a less 
compact perineurium, resulting in abnormal and interrupted TJ strands. Consequently, a 
defective nerve-tissue barrier is formed and extravasation of Evans Blue dye and immune 
cells invasion into the endoneurium occurs206. Therefore, our study further investigated 
the potential of the Hh pathway in the formation of a mature, ordered and functionally 
competent barrier. We demonstrate that astrocyte-derived Shh decreases permeability of 
soluble tracers in the modified Boyden chamber assay, an in vitro model of the BBB. 
Cyclopamine-injected mice endure acute BBB disruption as FITC-Dextran and 
endogenous serum proteins enter the brain parenchyma. We further demonstrate that Hh 
activation is essential for TJ expression, as cyclopamine induces a downregulation of 
junctional proteins in BBB-EC. Shh -/- mice exhibited a significantly lower expression of 
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claudin-5, occludin and ZO-1 on BBB-ECs in vivo, confirming the validity of the in vitro 
observation.  
 The activation of the Hh pathway involves activation of the downstream 
transcription factor Gli-1 which act as an activator to mediate and/or amplify the Hh 
signal as it is transcriptionally induced by Hh signaling in nearly all contexts 
examined315. Our data using flow cytometry demonstrates that in Hh activation in BBB-
ECs induces an intracellular upregulation of Gli-1, which is cyclopamine-sensitive. 
However, further mechanisms in promoting BBB properties were sought. SOX-18 was 
found to be an endothelial specific transcription factor as in silico analysis of the claudin-
5 promoter revealed an evolutionary conserved SOX consensus binding site. In 
HUVECs, SOX-18 overexpression increases claudin-5 mRNA and protein expression 
while SOX-18 silencing reduces claudin-5 transcription and transendothelial 
resistance310. Our results suggest that Gli-1 activation proceeds SOX-18 upregulation. 
Whether or not Gli-1 directly upregulates SOX-18 is still not known but in different 
contexts, the Hh pathway has already been seen to regulate other members of the SOX 
family. Shh was seen to induce changes in families of transcription factors such as SOX, 
further altering the expression of downstream genes316. Expression of SOX-14 in spinal 
cords was found to be regulated by Shh in a dose-dependent manner317. In neuroepithelial 
cells Gli-2 binds to an enhancer region vital for SOX-2 expression necessary for NSC 
proliferation and differentiation318. In this context, we postulate that Smo activation 
modulates barrier properties by impacting on TJ protein expression via Gli-1 and SOX-
18.  
 The BBB is an important entity in keeping the CNS an immunologically 
privileged site, a region where immune cells access in infrequent319. Astrocytes are key 
regulators of BBB functions and have been shown to secrete a variety of factors that help 
promote and maintain BBB properties11,24,312,313. However, less often are the factors 
shown to regulate the immune quiescence of BBB-ECs. We present evidence suggesting 
a novel and unique role of Shh in the regulation of CNS immunity. During CNS 
inflammation such as MS, its animal model EAE, and following various cerebral insults, 
upregulation of chemokines and CAMs in BBB-ECs contribute to the recruitment of 
immune cells. We selected to study chemokines MCP-1/CCL2 and IL-8/CXCL8 for they 
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were found to be important chemokines produced by BBB-ECs238,320. BBB-ECs treated 
with hrShh or with purmorphamine significantly reduce the secretion of both MCP-
1/CCL2 and IL-8/CXCL8, further demonstrating anti-inflammatory action. In fact, MCP-
1/CCL2 significantly contributes to lymphocyte migration, as blocking MCP-1/CCL2 
reduces the severity of EAE and significantly inhibits migration of MS lymphocytes 
across BBB-EC monolayers320. We further show that BBB-ECs grown with ACM or 
treated with rhShh or a Smo agonist, purmorphamine, all activators of the Hh pathway, 
reduce the expression of ICAM-1 and VCAM-1, demonstrating anti-inflammatory 
potential. The fact that both adhesion molecules expression and chemokine secretion 
decreased suggested that BBB-ECs were less effective in recruiting lymphocytes to the 
site of inflammation, an act that was indeed observed in vitro.  
In MS, BBB breach concurs alongside with EC activation and lymphocyte 
infiltration. Since the Hh pathway seems capable of promoting barrier properties as well 
as reducing EC activation and lymphocyte recruitment, we observed the effect of 
inflammation on Hh components. We showed that human astrocytes exposed to TNF-α 
and IFN-γ upregulate Shh production. This was paralleled in situ by the increase in Shh 
immunoreactivity around blood-vessels in active MS lesions, when compared to NAWM 
of the same patient. As Shh has been observed to be upregulated in various cells after 
acute injury and wound healing, implicating an important role in cellular and tissue 
repair154,256, we postulate that inflammatory cytokines activate Shh production in 
astrocytes in order to promote repair of the BBB. Shh thus may serve a protective 
function in acute immune-mediated injury. Indeed, a stable form of Shh was previously 
shown to positively impact on nerve injury321.  In addition, due to its potential anti-
inflammatory activity shown herein, Shh upregulation could be also be beneficial in 
regulating and containing the inflammation.  
 In contrast, while BBB-ECs treated with TNF-α and IFN-γ upregulated both Ptch-
1 and Smo on their surface, the same could not be seen in vivo, in active MS lesions. This 
demonstrates a potential dysregulation of the pathway at the level of the BBB, and 
provides a plausible explanation to BBB compromise. Recent studies have observed that 
Gli-1 was upregulated in active MS lesions, but was significantly downregulated in 
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chronic active and inactive lesions265, suggesting that long term inflammation impairs 
Gli-1 signal in chronic inflammatory conditions.  
In chronic gastrointestinal inflammation, Shh is also upregulated in epithelium of 
areas of inflammation such as in gastritis, Crohn’s disease and ulcerative colitis, an effect 
that was linked to the ability of injury-related cytokines to induce Hh production322. 
However, no increase in Ptch-1 mRNA and protein expression were observed in inflamed 
colonic epithelium, similarly to MS endothelium323. In a hypothetical model, it was 
suggested that injured epithelium, via the release of Shh, may communicate damage to 
both neighboring cells and to the immune system such as CD4+ T lymphocytes and 
macrophages that express Ptch-1 and thus capable of processing a Shh signal, a process 
that could further aid in repairing damaged epithelium 322-324.  
Identifying factors that are required for BBB integrity and maintenance is 
necessary for our understanding of neuroinflammation and specifically MS. These 
experiments allowed us to determine that the Hh pathway is an important astrocytic 
contributor to BBB integrity. These data also suggest that Shh acts as a direct negative 
regulator of CNS inflammation through its regulatory effect on BBB-EC activation. Our 
study will shed some light on a novel role of the Hh pathway in the CNS and help in the 
development of strategies to regulate the migration of immune cells, the delivery of drugs 
across the BBB and to design new therapies in the treatment of neuroinflammatory 
diseases such as MS. 
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Materials and methods 
Primary cell isolation & culture 
Human adult CNS tissue was obtained from temporal lobe resection paths of patients 
undergoing surgery for intractable epilepsy, as previously described223,325. Informed 
consent and ethic approval were given prior to surgery (ethic approval number 
HD04.046). BBB-ECs were isolated and grown in medium composed of M199 
(Invitrogen, Carlsbad, CA) supplemented with 10% feral bovine serum (FBS), 20% 
normal human serum (HS), endothelial cell growth supplement (5mg/ml) and insulin-
selenium transferring premix on 0.5% gelatin-coated tissue culture flasks (reagents from 
Sigma, Oakville, ON, Canada). Expression of EC markers von Willebrand Factor VIII 
and Ulex europaeus agglutinin I binding sites until passage (P) 7-8 were confirmed. No 
immunoreactivity for α-myosin or glial fibrillary acidic protein (GFAP) could be 
detected, confirming the absence of contaminating smooth muscle cells and astrocytes. 
Human fetal astrocyte isolation has previously been described326,327. Briefly, fetal CNS 
tissue was obtained at 16-22 weeks of gestation following CIHR-approved guidelines. 
Astrocytes were cultured in complete Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with 10% FBS, glutamax, penicillin and streptomycin (Sigma). Cultures 
were determined to be >90% pure, as determined by GFAP immunostainings, and used 
between P3-6. Once a week, ACM was harvested from confluent flasks, filtered and 
added to BBB-EC culture media when specified43. 
Immunocytofluorescence 
Primary cultures of BBB-ECs and astrocytes were grown to confluency in 8 chamber 
slides and fixed with 4% paraformaldehyde (PFA) or methanol (10min, RT). Slides were 
subsequently permeabilized with 0.3% triton X-100 (5min, RT) and blocked by 
incubation in 10% goat serum (1h, RT, Sigma) for 1h at RT. Primary antibody (Ab) 
incubation with rat anti-Shh (1/50, R&D Systems, Minneapolis, MN), rabbit anti-Ptch-1 
(1/50, Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit anti-Smo (1/200, MBL, 
Woburn, MA) were done overnight at 4˚C. Following washes, signals were amplified 
using biotin-conjugated anti-rat and anti-rabbit Abs followed by Cy3- or FITC-labeled 
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streptavidin (1/400 and 1/1000 respectively, 30min, RT; DakoCytomation, Glostrup, 
Denmark). GFAP staining was revealed with Cy3-conjugated anti-mouse Ab (1/400, 
30min, RT; Jackson ImmunoResearch Laboratories, West Grove, PA). Nuclei were 
stained with TO-PRO3 (1/300 in PBS, 30min, RT; Molecular Probes, Eugene, OR).  In 
all cases, control stainings were performed using isotype controls and no immunopositive 
cells could be detected. Staining was visualized using the Leica SP5 confocal microscope 
and analyzed using the Leica LAS AF software.    
Tissue and immunohistochemistry 
Brain tissue from 13 patients with clinically diagnosed and neuropathologically 
confirmed MS was obtained at rapid autopsy and immediately frozen in liquid nitrogen. 
Three cases without neurological disease were selected as controls. Tissue samples 
control cases were taken from the subcortical white matter, corpus callosum and cortex. 
White matter MS tissue samples were selected on the basis of post-mortem MRI and 
lesions were classified according to standard histopathological criteria328,329. Based on 
these findings, 6 lesions sampled in this study were classified as active with abundant 
phagocytic perivascular and parenchymal macrophages containing myelin degradation 
products, 7 lesions as chronic active with a hypocellular demyelinated center and a 
hypercellular rim containing numerous macrophages and 6 lesions as chronic inactive 
with only a few leukocytes and extensive cell loss. All patients and controls, or their next 
of kin, had given informed consent for autopsy and use of their brain tissue for research 
purposes.  
The generation of Shh deficient mice has been described previously150. Mouse embryos 
(either Shh-/-, Shh+/- or WT) were extracted and snap frozen. Similarly, the C57Bl/6 
adult mice, used for the in vivo experiments, were perfused with 5ml of PBS and brain, 
spleen and liver were removed and quickly snapped frozen.  
For immunohistochemical and fluorescent staining, 5-8 μm cryosections were cut, air 
dried and fixed in acetone for 10min. Sections were preincubated for 30min at RT with 
20% animal serum, the source of which was determined by the specific secondary Ab 
used. Afterwards, sections were incubated overnight at 4˚C with primary Abs for 
Proteolipid protein (1/500, Seorotec Ltd, Oxford, UK, MHC II (1/100, DakoCytomation), 
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Shh (1/200, R&D systems), Ptch-1 (1/300), Smo (1/200, Santa Cruz Biotechnology), 
fibrinogen (1/1000, Innovative Research, Novi, MI), occludin, claudin-5, or ZO-1 (1/200, 
Zymed, South San Francisco, CA). Subsequently, for immunohistochemistry, sections 
were incubated with appropriate secondary biotin-labeled Abs for 1h at RT and with 
ABC (DakoCytomation) according to the manufacturer's description. Diaminobenzidine 
(DAB) was used as chromogen. Between the incubation steps, sections were thoroughly 
washed with PBS. After a short rinse in tap water, preparations were incubated with 
hematoxylin (Sigma) for 1min and extensively washed in tap water for 10min. Finally, 
sections were dehydrated with ethanol, followed by xylol and mounted with Entellan 
mounting media (Canemco & Marivac, Lakefield, Quebec, Canada). For 
immunohistofluorescence, sections were incubated with appropriate secondary Cy3-
labeled Abs (1/400, DakoCytomation) for 1h at RT. FITC-conjugated Lycopersicon 
Esculentum (Tomato) lectin (1/200, 1h, RT, Vector Laboratories, Burlingame, CA) was 
used to provide a frame of reference for the localization of blood vessels and nuclei were 
stained with Hoechst 33258 dye (1/5000, 1min, RT, Invitrogen) and/or with TOPRO-3 
(1/300, 30min, RT, Molecular Probes). In all cases, Abs were diluted in PBS containing 
0.1% blocking serum, which also served as a negative control. Stainings were visualized 
using either a Leica DM6000 microscope with OpenLab software or the Leica SP5 
confocal microscope. 
 
Reverse-transcription and real-time quantitative polymerase reaction 
Cellular RNA was isolated using the TRizol reagent (Invitrogen) and Qiagen RNeasy 
Mini extraction kit (Mississauga, Ontario), according to the manufacturers’ instructions. 
RNA concentration and purity were determined on a spectrophotometer Ultrospec 2100 
pro at 260 nm. Samples were then treated with DNAse I (Amersham Biosciences, 
Piscataway, NJ) for 10min at 37˚C followed by 10min at 75˚C. Complementary DNA 
(cDNA) was obtained by mixing 3 µg of RNA with 3.3µM random hexamer primers, 
3mM dNTPs, RNase-OUT recombinant ribonuclease inhibitor, 3nM DTT and 400U 
Maloney murine leukemia virus (MMLV)-reverse transcriptase for 1h at 42˚C and 10min 
at 75˚C (Invitrogen). For polymerase reactions (PCRs) to be run on agarose gel, 2 µl of 
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cDNA were amplified using 5U Taq DNA polymerase, 1.5mM MgCl2, 0.2mM dNTPs 
and 50pmol of forward (F) and reverse (R) primers. Primers used were: Shh; F: 5’-
AAAAGCTGACCCCTTTAGCC-3’; R: 5’-CTCTGAGTGGTGGCCATCTT-3’; Ptch-1; 
F: 5’-GTCGCACAGAACTCCACTCA-3’; R: 5’-AAGAGCGAGAAATGGCAAAA-3’; 
Smo; F: 5’-CAACCTGTTTGCCATGTTTG-3’; R: 5’-ACATCAGCTGAGGGCTCATT-
3’; Gli-1 F: 5’-CGGGGTCTCAAACTGCCCAGCTT-3’; R: 5’-
GGCTGGGTCACTGGCCCTC-3’330; GAPDH; F: 5’-CAAAGTTGTCATGGATGACC-
3’; R: 5’-CCATGGAGAAGGCTGGGG-3’ (all primers ordered from Invitrogen). The 
reaction mixtures were placed in an Eppendorf ‘mastercycler’ thermal cycler for 10min at 
94˚C, followed by 30-35 cycles of 94˚C for 1 min, 45sec at 60˚C and 1min at 72˚C. After 
amplification, 15µl of each sample was resolved on a 1.5% agarose gel with ethidium 
bromide. Real-time quantitative PCR was performed for four genes: ribosomal 18S RNA 
(as an internal amplification control), Gli-1, SOX-18, and claudin-5 (primers from 
Applied Biosystems, Foster City, CA). The amplification was performed in the presence 
of AmpliTaq Gold DNA Polymerase, AmpErase UNG, dNTPs with dUTP, Passive 
Reference (ROX), and optimized buffer components according to manufacturer’s 
instructions. For 18S amplification, 200 nM of internal probe conjugated to VIC dye and 
50 nM of the forward and reverse primers were added. For the target genes, 12.5 nM 
FAM-labeled probe and 45 nM of the forward and reverse primers were added (Applied 
Biosystems). Each sample was run in a 96-PCR plate incubated in 7900 Fast Real Time 
PCR System (Applied Biosystems) for 2min at 50°C, 95°C for 10min, followed by 40 
cycles of PCR (95°C for 15 sec and subsequent 60°C for 1min). The relative expression 
of each target gene was compared to ribosomal 18S and ΔCT (CT (target) - CT (reference)) was 
calculated. 
 
Western blots 
 
For western blot analysis (WB) of whole cell lysates, astrocytes and BBB-ECs were lysed 
in denaturing buffer (50mM Tris-HCl pH 8.5 and 0.1% SDS) supplemented with protease 
inhibitors, sonicated and centrifuged at 10,000g for 10min at 4˚C. Electrophoresis of 
35µg of the supernatant was performed on 6-10% SDS-polyacrylamide gels under 
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reducing conditions. For WBs of supernatants, 100μg of chloroform-precipitated ACM 
and control DMEM (supplemented ± with 0.1μg/ml of hrShh) were used. Proteins were 
transferred to polyvinylidene difluoride (PVDF) membranes (Biorad, Hercules, CA) and 
blocked for 1h at RT in 5% milk. Membranes were then incubated overnight with rat 
anti-human Shh (1/500, R&D systems), rabbit anti-human Ptch-1 Ab (1/250, Santa Cruz 
Biotechnology), rabbit anti-claudin-5, rabbit anti-occludin (1/150, Zymed), mouse anti-
JAM-A (1/500, BD Biosciences), or mouse anti-β-actin (as loading control, Sigma) 
followed by 1h incubation with species-specific horseradish peroxidase (HRP)-
conjugated Abs (DakoCytomation). All signals were revealed using ECL reagents 
(Amersham Biosciences). 
 
Permeability and migration assays 
Primary cultures of BBB-ECs were used to generate an in vitro model of the human 
BBB, as previously reported238,320,331. BBB-ECs were plated on gelatin-coated 3µm pore 
size Boyden chambers (BD Biosciences, Franklin Lakes, NJ) at a density of 2x104 cells 
per well in EC culture media, supplemented with 40% (v/v) ACM when applicable, and 
were allowed to grow for 72h to reach confluency. At 48h, cells were treated with hrShh 
(0.1μg/ml, Sigma), Smo agonist purmorphamine (1μM), or Smo antagonist SANT-1 
(0.1μM, Calbiochem Biochemicals, Darmstadt, Germany) or cyclopamine (30μM, 
Sigma). At 72 hours, FITC-labelled bovine serum albumin (BSA; 50μg/ml; Invitrogen), 
14C-sucrose (250nCi/ml; MP Biomedicals, Aurora, OH) or 1x106 freshly purified human 
CD4+ lymphocytes sorted by magnetic cell sorting (MACS) isolation columns (Miltenyi 
Biotec, Auburn, CA) were added to the upper chambers. Tracer diffusion across the EC 
monolayer was assessed by sampling upper and lower chambers at specific time points.  
Fluorescence intensity in the media was monitored using a FL600 microplate fluorescent 
reader (Biotek, Winooski, VT). Molecular tracer diffusion representing BBB 
permeability is calculated using the formula [tracer lower chamber] X 100 / [tracer upper 
chamber]. The radioactive isotype 14C was read using A2100 Packard Instruments liquid 
scintillation analyzer (Downers Grove, IL). Immune cell migration was assessed 24h 
following lymphocyte addition by recovering the migrated cells in the lower chamber 
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with 0.1M EDTA, stained with trypan blue, and counted using a hemacytometer under 
blinded conditions. Dead cells were excluded from total counts of migrated cells (1% of 
cells). 
 
In vivo permeability 
To establish BBB disruption in vivo, 7-8 week old C57Bl/6 (Charles Rivers, Wilmington, 
MA) were injected intra-peritoneally (i.p.) with a single dose of cyclopamine at a 
concentration of 10mg/kg or with equal volume of its vehicle (45% Hydroxypropyl-β-
cyclodextrin, HPBCD, Sigma)332. Following a waiting period of 6h, 0.1ml of 70kDa 
FITC-conjugated Dextran (1mg/ml) was injected intravenously (i.v.) into the tail vein of 
each animal, prior to 0.1ml pentobarbital i.p. injection. Microscopic visualization of the 
extravasation of Dextran-FITC, as well as the plasma protein fibrinogen was done on 
brain cryosections and images several blood vessels from vehicle and cyclopamine-
injected animals were taken using identical camera settings to allow comparison of 
extravasation. The area (number of pixels) and fluorescent intensity of the signal (mean 
intensity of pixels) of both the Dextran-FITC and fibrinogen stainings surrounding 
vessels were measured using ImageJ. The relative extent of fluorescent extravasation and 
BBB disruption was then calculated by multiplying the area of pixels with the mean 
intensity of pixels. 
 
Flow cytometry and enzyme-linked immunosorbent assay 
Confluent BBB-ECs were treated for 24h with fresh media supplemented with 40% 
ACM, purmorphamine (1μm, 24h), SANT-1 (0.1μm, 24h), cyclopamine (30μm, 24h), 
hrShh (0.1μg/ml, 24h, Sigma), or with IFN-γ and TNF-α (R&D Systems). Quantitative 
changes in cytokine production were assessed from culture supernatants by enzyme-
linked immunosorbent assay (ELISA) for IL-8/CXCL8 and MCP-1/CCL2 (BD 
Biosciences), according to the manufacturer’s protocol. Treatments with ACM could not 
be done for the possible source of IL-8/CXCL8 or MCP-1/CCL2 found in the ACM, 
resulting in non-conclusive analysis. Plates were read using a Bio-Tek EL800 96-well 
 79
plate reader at a 450nm wavelength and analyzed using KC Junior program (Bio-Tek, 
Mississauga, ON, Canada). 
From the same experiments, extracellular stainings of confluent BBB-ECs were 
performed after trypsin recovery. The cells were then incubation in 10% fetal bovine 
serum with 20μg/ml of rabbit anti-Ptch-1 (Santa Cruz Biotechnology) or rabbit anti-Smo 
(MBL) for 30min at 4°C. Following a wash, the cells were reincubated in 10% FBS with 
2ul of FITC-labeled goat anti-rabbit and 5ul of anti-CD54 (ICAM-1) and anti-CD106 
(VCAM-1; both from BD Biosciences) for 30min at 4°C. Cell staining was acquired on a 
LSRII (BD Biosciences) and analyzed using FACSDiva software. 
For intracellular cytokine staining (ICS), primary cultures of astrocytes were stained for 
HLA-ABC coupled to Pacific Blue and were then fixed and permeabilized in 4% (w/v) 
PFA with 0.1% (w/v) saponin in Hank’s Balanced Salt Solution (10min at RT). 
Intracellular staining was performed by incubating cells with Abs against Shh or Gli-1, 
(5μg/ml, R&D systems) for 30 min on ice in PBS buffer containing 0.1% (w/v) saponin, 
1% FBS, 0.1% (w/v) NaN3, followed by a wash and another reincubation with 2ul of 
APC-labeled donkey anti-rat (eBioscience, San Diego, CA) resuspended in FACS buffer 
[1% (v/v) FBS, 0.1% (w/v) NaN3 in PBS]. Cells were acquired on a BD LSRII and 
analyzed using BD FACSDiva software. 
 
Statistical analysis 
Data were analyzed using GraphPad Prism software (San Diego, CA, USA). Results are 
shown as mean and standard error of the mean (SEM) and statistical analyses included 
paired student’s t-test. 
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Figure legends 
 
Figure 1: Human astrocytes express and secrete Sonic Hedgehog and human blood-brain 
barrier endothelial cells express receptor, Patched-1 and signal transducer Smoothened. 
A. Polymerase chain reaction (PCR) of primary cultures of human fetal astrocytes (HFA; 
two preparations are shown: 1 and 2) and human adult blood-brain barrier (BBB) 
endothelial cells (ECs; two preparations are shown: 3-4). B. Protein expression of 
Hedgehog (Hh) pathway components by astrocytes and BBB-ECs revealed by western 
blots (WBs). Whole cell lysates from BBB-ECs and HFAs were solubilized in denaturing 
buffer, resolved on 8% SDS-PAGE gels and immunoblotted using anti-human antibodies 
(left panels). Precipitated astrocyte-conditioned media (ACM) contains the cleaved form 
of Sonic Hh (Shh) at 19kDa. Human recombinant Shh (hrShh) protein was used as a 
positive control (right panel). Gels shown are representative of 3 independent 
experiments (n=3). C. Protein localization of Hh pathway components in HFAs and 
BBB-ECs detected by immunocytofluorescence. Primary cultures of HFAs and BBB-ECs 
were plated in chamber slides, fixed with paraformaldehyde 4% or methanol 100% and 
stained using anti-human antibodies. Intracellular staining of Shh (green) was found in 
GFAP immunopositive (red) HFAs. BBB-ECs showed surface expression for the receptor 
Patched-1 (Ptch-1), and the co-receptor, Smoothened (Smo). Merged overlay are shown 
(right panels). Hoechst-stained nuclei are blue. Scale bars represent 50μm. No staining 
was detected in controls lacking primary antibodies. D. In adult human CNS tissue, 
perivascular astrocytes express Shh as determined by the location and morphology of the 
cells. Higher magnification of perivascular astrocyte (arrowhead) shows the cell body and 
endfeet (arrows) opposing parenchymal vessel (asterisk). Ptch-1and Smo expression in 
human CNS tissue was detected in human brain vascular endothelial cells. Nuclei were 
counterstained with haematoxylin. Scale bar represents 50μm. All stainings were 
performed on 5-8 µm frozen sections of control non-pathological human brain tissue 
(n=10).  
 
Figure 2: Astrocyte secreted Shh decreases BBB-EC permeability via Smo signaling. A-
C. In the in vitro assay for permeability, BBB-ECs are plated in the top chamber and 
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grown to confluency. After treatment, Fluorescein Isothiocyanate-bovine serum albumin 
(FITC- BSA) is added to the top chamber and the time course of its diffusion is 
measured. A. When BBB-ECs are grown in ACM, permeability of BSA-FITC decreases 
by 40%. (▄, n= 8, *p <0.05) when compared to cells grown under basal conditions (○, 
untreated). Similar effects were obtained when BBB-ECs monolayers were treated with 
hrShh (▼, 0.1 μg/ml; 24h, n=8, *p<0.05) or B. purmorphamine (▼, 1μM; 24h, n=8, 
*p<0.05). C. The effect of ACM on the permeability of BBB-ECs was prevented by 
treating the cells with the antagonist cyclopamine (▲, 30μM; 24h, n=6, p<0.05) or 
SANT-1 (not shown), suggesting that Shh ligand is responsible, at least in part, for the 
barrier promoting effects of astrocytes. D. The relative extent of BBB leakage was 
studied in the CNS parenchymal tissue of mice intraperitoneally injected with 
cyclopamine (10mg/kg in 45% Hydroxypropyl-β-cyclo-dextrin, HPβCD, 6h). BBB 
disruption was determined with a 70 kDa Dextran-FITC injected in the tail vein 5min 
prior to sacrifice and by measuring exogenous fibrinogen. Quantitative analysis of 
Dextran-FITC and fibrinogen extravasation was significantly higher in cyclopamine-
injected animals, compared to vehicle-injected mice (*p<0.05 for both markers). E. 
Parenchymal vessels (asterisk) showed various points of BBB leakage (arrowheads) in 
the cyclopamine-treated mice. Both FITC-Dextran and fibrinogen leakage into the 
surrounding parenchymal tissue was detected at the breaking points (arrowheads). In the 
vehicle treated mice (HPβCD), Dextran-FITC and fibrinogen staining were found solely 
in the lumen of the vessels. Hoechst stained nuclei are blue. Scale bars represent 50μm. 
  
Figure 3: Shh is important in tight junction maintenance. A. Quantitative, real-time PCR 
reveals that BBB- ECs grown with ACM or with hrShh (0.1μg/ml, 24h) upregulates Ptch-
1 expression. Claudin-5 and occludin were also upregulation upon Hh activation. B. WB 
(left panels) resolved on 8% SDS-PAGE gels and immunostained for tight junction (TJ) 
proteins claudin-5, occludin and JAM-A on BBB-EC whole cell lysates, showed 
downregulation of all three proteins after ACM-grown BBB-ECs were treated with 
cyclopamine (30μM, 24h; 35 µg of protein/well), compared to ACM-grown BBB-ECs. 
Semi-quantitative graph shows claudin-5 downregulation of 21.3%, occludin of 77.9%, 
and ZO-1 of 32.4%, compared to ACM control. C. Shh knock-out (-/-) embryonic mouse 
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brains exhibited reduced levels of claudin-5, occludin, and ZO-1 on lectin+ BBB-ECs, 
compared to WT animals. Overlays are shown (bottom panels) with TOPRO-3 nuclei 
stained in blue. Left corner insets demonstrates lectin+ ECs positive for claudin-5, 
occludin, or ZO-1 in WT mice, compared to loss of TJ positivity in Shh -/- mice. Scale 
bars in fluorescent pictures represent 50μm. D. Quantification plot of the number of 
lectin+ ECs immunopositive for the TJ proteins claudin-5, occludin, or ZO-1. Compared 
to WT BBB-ECs, Shh -/- had significantly less lectin+/claudin-5+ (n=10, ***p<0.0001), 
lectin+/occludin+ (n=5, ***p<0.0001), and lectin+/ZO-1+ (n=10, ***p<0.0001) cells.  
. 
Figure 4: Modulating Hh activity influences BBB-EC expression of cell adhesion 
molecules, chemokine secretion and leukocyte ability to transmigrate. A. Flow cytometry 
analysis of the cell adhesion molecules (CAMs), intercellular-CAM-1 (ICAM-1) and 
vascular-CAM-1 (VCAM-1), was determined on BBB-ECs. When grown in  ACM, both 
surface VCAM-1 and ICAM-1 levels decreased to 1.7% and 63.9%  from control 
(untreated) conditions of 3.4% and 73.9%, respectively. This reduction could be inhibited 
if cyclopamine (30μM, 24h) was added to the ACM. When treated with exogenous hrShh 
(0.1μg/ml, 24h) or purmorphamine (1μM, 24h), VCAM-1 and ICAM-1 surface 
expression on BBB-ECs reduced to levels of 2.2-2.8% and 59.3-66.6%, respectively. B. 
Mean fluorescent intensity was measured for ICAM-1 in BBB-ECs. Activation of the Hh 
pathway in ACM-grown BBB-ECs as well hrShh and purmorphamine treatments 
decreased the intensity of ICAM-1 signal on BBB-ECs (n=3, *p<0.05), an effect that 
could be blocked by cyclopamine treatment. C. BBB-EC chemokine secretion was 
detected by enzyme-linked immunosorbent assay (ELISA). Treating primary cultures of 
human BBB-ECs with hrShh (0.1μg/ml, 24h) or purmorphamine (1μM, 24h) lead to a 
decrease in secretion for both IL-8/CXCL8 and MCP-1/CCL2 chemokines (n=4, 
**p<0.005, ***p<0.0005, respectively). Addition of cyclopamine (30μm, 24h) to hrShh 
(0.1μg/ml, 24h)-treated BBB-ECs inhibited the decrease in chemokine secretion. D. 
CD4+ T lymphocyte migration was measured using the modified Boyden chamber assay. 
2x106 human CD4+ lymphocytes (n=4 donors) were allowed to migrate across untreated 
BBB-ECs or ACM-grown BBB-ECs. Data demonstrates that ACM promotes the BBB 
capacity to restrict immune cell migration. BBB-ECs treated with hrShh (0.1μg/ml, 24h) 
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or with purmorphamine (1μM, 24h) restricted the migration of CD4+ leukocytes across 
the monolayer. ACM-grown BBB-ECs treated with cyclopamine (30μM, 24h) permitted 
the migration of lymphocytes to the same degree as the untreated control (*p < 0.05, 
**p<0.005, ***p < 0.0005, n=8, in duplicate).  
 
Figure 5: In vitro expression pattern of transcription factors in BBB-ECs. A. Flow 
cytometry analysis of the transcription factor Gli-1 was determined intracellularly in 
BBB- ECs. In resting conditions, Gli-1 was expressed in 26.7% of the cells (compared to 
normal rat isotype control, outline shown in black). Gli-1 expression increases in ACM- 
grown-BBB-ECs (dark grey) to 43.1%, compared to untreated control (light grey). The 
effect of cyclopamine (light grey, 30μM, 24h) reversed the effect of the ACM 
upregulation of Gli-1 down to 38.8%, suggesting that ACM drives Gli-1 upregulation via 
Smo. BBB-ECs treated with hrShh (dark grey, 0.1μg/ml, 24h) and purmorphamine (dark 
grey, 1μM, 24h) increased levels of Gli-1 to 45.3% and 65.4% respectively. B. Mean 
fluorescent intensity was measured for Gli-1 in BBB-ECs. Activation of the Hh pathway 
in ACM-grown BBB-ECs as well hrShh and purmorphamine treatments increased the 
intensity of Gli-1 signal in BBB-ECs (n=2, *p<0.05, **p<0.01), an effect partially 
blocked by cyclopamine treatment. C. Quantitative real-time PCR experiments 
demonstrated the time course of Gli-1 and SOX-18 transcription factor upregulation upon 
hrShh treatment. Rapid induction of Gli-1 mRNA upregulation occurs 1h after Shh 
treatment (0.1μg/ml). Following Gli-1 upregulation, SOX-18 mRNA levels increase after 
3h following hrShh treatment (n=2, **p<0.01, ***p<0.001). 
 
Figure 6: Pro-inflammatory cytokines upregulate Hh components in astrocytes and BBB-
ECs in vitro.  A. Flow cytometry analysis of Shh ligand was determined intracellularly in 
primary cultures of human astrocytes. Triple staining with GFAP and MHC-I identified 
the astrocytes (GFAP+/MHC-I+) from the potentially contaminating neurons (GFAP-
/MHC-I-, approximately 5% of population). Forward scatter (FSC, y-axis) and side 
scatter (SSC, x-axis) differentiates both cell volume and granulocity respectively. In 
resting astrocytes, Shh was expressed in 35.4% of the cells when compared to normal rat 
isotype control. Treatment with pro-inflammatory cytokines TNF-α and IFN-γ (100U, 
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24h) increased levels of Shh to 63.4%. B. Flow cytometry analysis of the Hh receptors 
Ptch-1 and Smo was determined on BBB-ECs when grown in ACM. 30.0% and 27.6% of 
ACM-grown BBB-ECs express surface Ptch-1 and Smo respectively (compared to 
normal rabbit isotype control, outline shown in black). When treated with pro-
inflammatory cytokines TNF-α and IFN-γ (100U, 24h), the expression of BBB-ECs 
express Ptch-1 and Smo nearly doubles to levels of 59.3% and 54.4%, respectively. 
. 
Figure 7:  Expression of Shh in MS tissue. Formalin-fixed MS brain material from 
autopsy contained normal appearing white matter (NAWM) as well as acute MS lesions 
with heavy perivascular mononuclear cell infiltrates and marked demyelination. A. Shh 
expression in human MS tissue is increased in active MS lesions compared to nearby 
NAWM (delineated by black line). B. Shh expression was observed in perivascular and 
parenchymal astrocytes (arrowheads) in the NAWM. C. In active MS lesions, 
hypertrophic astrocytes and astrocyte processes are strongly Shh immunopositive 
(arrowheads). D. Double fluorescent staining shows higher expression of Shh (green) in 
perivascular and hypertrophic endfeet (arrowheads) colocalizes with GFAP (red), as seen 
in overlay. Nuclear counterstaining with Hoechst (blue). 
 
Figure 8: Expression of Hh components in MS tissue. Formalin-fixed MS brain material 
contained Hh components Ptch-1, Smo and Gli-1. A. Immunostainings of NAWM of MS 
brain material showing expression of Ptch-1 on endothelial cells (arrowheads). In active 
demyelinating lesions Ptch-1 is expressed by macrophages (arrow), but absent in the 
vasculature (arrowheads). B. Smo is expressed by microglia (arrowhead) and in the 
cerebrovasculature (arrow) in the NAWM. Macrophages (arrowhead) and brain 
endothelial cells (arrow) are Smo immunopositive in active MS lesions. C. Double 
fluorescent staining shows that expression of Ptch-1 (red) colocalizes with Gli-1 (red) in 
endothelial cells in NAWM, as seen in overlay. No considerable change in expression of 
Ptch-1 and Gli-1 are observed in active MS lesions. Gli-1 staining can be distinguished in 
infiltrating cells. Nuclear counterstaining with Hoechst (blue).  
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Supplemental Figure Legend 
 
Supplemental Figure 1: Activation of Hh pathway is dose-dependent and affects 
permeability of small molecule tracer 14C-sucrose, without affecting proliferation. A.  
hrShh decreases permeability of BBB-EC monolayers to BSA-FITC in a dose dependent 
fashion, with higher concentrations of hrShh leading to lower the diffusion rates of BSA-
FITC. B. Due to the progressive halving of carboxyfluorescein succinimidyl ester (CFSE) 
fluorescence within daughter cells following each cell division, cell proliferation can be 
compared between treatments. Compared to untreated control BBB-ECs, hrShh 
(0.1μg/ml, 24h) does not induce an increase in cell proliferation. C. In the in vitro assay 
for permeability, BBB-ECs are plated in the top chamber and grown to confluency. After 
treatment, small molecule tracer 14C-sucrose is added to the top chamber and a 6 hour 
time course of its diffusion is measured. When BBB-ECs are grown in ACM (▲, 40%) 
or treated with hrShh (▼, 0.1 μg/ml; 24h) or purmorphamine (, 1μM; 24h, n=8, 
*p<0.05), permeability of 14C-sucrose decreases, compared to cells grown under basal 
conditions (○, untreated). The effect of ACM on the permeability of BBB-ECs was 
prevented by treating the cells with the antagonist cyclopamine (▲, 30μM; 24h, n=6, 
p<0.05). 
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1.0 LIPID MEMBRANE RAFTS IN BBB 
 Membrane lipid rafts are cholesterol and sphingolipid-enriched platforms which 
compartmentalize specialized cellular processes. In BBB-ECs, they serve as organization 
centers for various endothelial-specific TJ, ECM-scaffolding, adhesion and transporter 
molecules. Mspect analysis of DRMs isolated from human primary cultures of BBB-ECs 
has confirmed the presence of proteins involved in such BBB-related activities, 
suggesting a crucial role of lipid membrane rafts in maintaining segregated and highly 
organized regions within the plasma membrane.  
 
1.1 Role of membrane lipid rafts in junctional protein complexes 
 
TJs consist of at least three known types of transmembrane proteins, including 
occludin, claudins and the junctional adhesion molecules (JAMs)8,17,25,26. Overall, the 
expression levels of TJ proteins have been found to decrease in many neurological 
disorders that are characterized by loss of BBB permeability integrity, such as in 
MS15,43,45,46. AJs of BBB-ECs are primarily composed of vascular endothelial cadherin 
(VE-cadherin), which interact with intracellular proteins, including the different catenin 
isoforms (α-, β-, γ-catenin) and ZO-1 to create the association with the actin 
cytoskeleton54,59-62. Nusrat and coworkers first proposed that TJ molecules of epithelial 
cells were enriched in lipid raft membrane microdomains. Using the T84 intestinal 
epithelial cell line and TX-100 raft isolation procedures, occludin and ZO-1 were found 
to be significantly increased in the insoluble fractions compared to the non-raft soluble 
fractions293. This functional membrane raft idea was adopted by others and recent 
publications confirmed the close association of membrane rafts with various TJ and AJ 
proteins in both endothelial and epithelial cells43,286,333. In Part I of the current thesis, I 
demonstrate that TJ proteins occludin, JAM-A and ZO-1 are localized in BBB-EC lipid 
membrane rafts, alongside caveolin-1 (Figure ivA) .  
Distribution of TJ proteins to lipid rafts can occur via specific post-translational 
fatty acid modifications. Inhibition of palmitoylation, required for optimal claudin 
function, restricts claudin enrichment into DRM domains and leads to a decrease in TJ 
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barrier function334. Using a novel, detergent-free OptiPrep density-gradient method to 
fractionate rat cerebral microvessels, McCaffrey and co-workers observed TJ proteins in 
isolated raft fractions and found that the molecular weights of claudin-5, ZO-1 and 
occludin contained in rafts were twice as large as the predicted weights. This suggests 
that raft microdomains could be an environment in which TJ oligomerization 
occurs285,286,335. Other studies show that alterations in caveolin-1 expression induces 
alterations of the TJ and AJ complexes277,336 and caveolin-1 -/- mice suffer from 
microvascular hyperpermeability337. In addition, caveolin-1 knock-down in BBB-ECs 
induced a shift in occludin, VE-cadherin and β-catenin subcellular distribution from the 
DRM to the soluble fraction along with an increase in endothelial permeability277. Taken 
together, these data demonstrate that specialized rafts contribute to barrier permeability 
through clustering of TJ and AJ proteins. 
Several chemicals, described to affect cholesterol synthesis or availability, are 
known to modulate raft integrity. Modulation of cell membrane cholesterol by treating 
cells with the cholesterol chelator methyl-β-cyclodextrin (MβCD) induces an initial rise 
and subsequent fall in TEER measures, associated with actin redistribution and reduced 
membrane expression of occludin and ZO-1338,339. Moreover, it has been demonstrated 
that MβCD treatment leads to specific displacement of occludin, claudin-3, -4, -7 and 
JAM-A out of the Lubrol WX-resistant lipid rafts and coincides with a decrease in TJ 
integrity340. Cholesterol lowering agents, such as HMG-CoA reductase inhibitors (i.e. 
statins) induced the mobilization of occludin outside of the raft compartment in epithelial 
cells293. In the human in vitro system however, statins were shown to decrease BBB 
permeability without altering subcellular localization of occludin, JAM-A, VE-cadherin, 
ZO-1 or ZO-2254. This suggests that protein localization into rafts is not uniquely 
regulated by cholesterol concentration, and that additional effects of statins, unrelated to 
their cholesterol lowering effects might account for these discrepancies. In that sense, we 
and others have also shown that the barrier promoting effect of statins was dependent on 
their effect on geranylation, and independent on the cholesterol concentration254,341.  
TJ enrichment within membrane rafts is positively influenced by astrocyte-
secreted angiotensin metabolites and is negatively regulated by pro-inflammatory 
cytokines43. Similarly, additional proteins secreted by astrocytes can modulate the BBB-
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EC TJ microdomains, such as the chemokine MCP-1/CCL2 acting via its receptor 
CCR2342. MCP-1 was reported to induce changes in caveolin-1 expression and to impact 
on ZO-1 and occludin localization in membrane microdomains, suggesting that during 
inflammatory conditions, BBB destabilization can occur through inflammatory cytokine-
induced reorganization of TJ proteins on the BBB-EC surface343.  
In addition to junctional proteins, there are several reports associating integrins 
with caveolae and lipid rafts344. Membrane rafts in ECs are enriched in α5β1 integrin, 
which binds to ECM components and mediates EC attachment to the basal lamina345,346. I 
showed that these integrin subunits, in addition to α5 can be identified in BBB-EC lipid 
membrane rafts (Figure ivC), suggesting that lipid membrane rafts can be a crucial 
component to preserving integrin polarity within the cell. 
 
1.2 Role of lipid membrane rafts in adhesion molecules 
 
The association of CAMs with cholesterol-enriched membrane microdomains is 
important for optimal signal transduction events during both transendothelial and 
transjunctional migration. ICAM-1 and novel adhesion molecules ALCAM and MCAM 
have been found to localize partially in DRMs (Figure ivB), suggesting a potential 
functional role of lipid rafts in cell adhesion processes. Accordingly, knock-down of lipid 
raft-associated protein caveolin-1 in ECs was shown to inhibit transendothelial leukocyte 
migration347. Recent studies using non-CNS derived endothelium and epithelial cultures 
have identified novel molecules that coordinate leukocyte transmigration, including 
JAMs, CD44, CD47, CD73348, CD90349, CD137350, CD81351 and CD166/ALCAM23. 
Most of these adhesion molecules are enriched in lipid rafts derived from primary 
cultures of human BBB-ECs23. PECAM-1 is also known to act on leukocyte migration, 
but has rather been documented to halt leukocyte emigration, as PECAM-1 -/- animals 
have enhanced immune cell infiltration into the CNS352. ICAM-1 and PECAM-1 are 
enriched in lipid membrane rafts and signal through lipid raft platforms231,333,353.  
During the final phase of transmigration, complex intracellular signaling events 
take place in both the leukocyte and the EC to prepare the cells for 
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transmigration/diapedesis. These events are dependent on adhesion molecule signaling 
and include cytoskeleton remodeling, TJ and AJ disassembly and reassembly and cell 
body retraction. Recent data from Greenwood and colleagues support the notion that VE-
cadherin re-localization in BBB-ECs during diapedesis is dependent on ICAM-1 
signaling events mediated by membrane raft signaling platforms. ICAM-1 signaling lead 
to VE-cadherin phosphorylation and allow paracellular leukocyte migration333. As 
recently described, a key feature of transendothelial migration (also called 
emperiopolesis) is the formation of an EC cup-like structure surrounding the migrating 
leukocytes218,219,354-357. Endothelial membranes positive for caveolin-1 are associated with 
the transmigrating leukocyte in the transmigration cup, which is dependent on the 
presence of lipid rafts and their recruitment of CAMs347. In this context, lipid rafts are 
believed to coordinate outside-in signaling in ECs and regulation of actin remodeling by 
lipid raft associated small GTPases, such as Rho40,358,359 and Rac360,361, myosin dependent 
contractions362 and junctional protein regulation43,363. These transendothelial migration 
events are highly organized around CAM-mediated signaling within lipid membrane raft 
structures and support the concept of functionally distinct adhesion-specific endothelial 
membrane rafts.  
 
1.3 Proteomic analysis of BBB-EC lipid membrane rafts reveal proteins typically 
associated with the nervous system 
  
 Lipid membrane raft isolated from human BBB-ECs and LC-MSpect identified 
proteins in BBB-related functions, such as junctional, adhesion and transporter 
molecules. Proteins involved in intracellular trafficking, cytoskeleton remodeling and 
signal transduction were also found. In addition, further analysis of specialized cellular 
functions revealed candidate molecules usually involved in nervous system functions, 
notably in synaptic transmission, axon guidance, morphogenesis, and planar cell polarity 
(Figure v). A recent report described similar findings287.  Purified epithelial cell TJ 
complexes were subjected to MSpect and fingerprint analyses, and bioinformatic results 
identified unexpected clusters of synaptic and signaling proteins. For example, ion 
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channels and neurotransmitter transporters P/Q-type calcium channel subunit CPα1A, 
voltage-gated potassium channel Kv2.1, NMDA glutamate receptor zeta subunit, AMPA 
glutamate receptor subunit GluR and scaffold proteins including presynaptic piccolo as 
well as postsynaptic GRIP and Homer were found in the TJ microdomain. To make sense 
of the results, the author describes noteworthy functional and structural features shared 
between the TJ and the neuronal synapse287. As for neuronal and synapse associated 
proteins may function in association with the TJ proteins, additional functions are 
plausible. Due to no known studies on the possible use of the Hh pathway in BBB 
functions, this subject was selected to be studied.  
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2.0 THE Hh SIGNALING PATHWAY 
2.1 The Hh signaling pathway in lipid membrane rafts 
 
 Although I have not extensively studied the importance of the Hh pathway in 
BBB-EC membrane rafts per se, lipid rafts are essential in maintaining a functioning Hh 
cascade. Lipid, cholesterol and sterols have been linked to the Hh signaling pathway 
since it was first shown that the Hh morphogen is covalently attached to lipid moieties364. 
In fact, diseases caused by defects in the final stages of cholesterol synthesis, such as 
Smith-Lemli-Opitz syndrome, desmosterolosis, and lathosteolosis, have been ascribed to 
defective Hh signaling365. Furthermore, embryonically disrupted cholesterol metabolism 
can lead to aberrant neural phenotypes which strikingly resemble Hh-deficient 
malformations, cyclopia and holoprosencephaly, demonstrating the close connection 
between cholesterol and Hh signaling168. 
Cholesterol prefers to associate with sphingolipids rather than phospholipids, due 
in part to the higher degree of saturation of the fatty acids in sphingolipids, which allows 
for a more favorable packing of the planar rings of cholesterol. Since Hh ligands are 
covalently linked to cholesterol, Hh should be able to associate with sphingolipids, and 
to, in this manner, confer affinity for lipid membrane rafts. Numerous reports have 
additionally identified Hh components in membrane lipid rafts. In Drosophila, Triton-
insoluble DRMs isolated from a density gradient have identified the Hh ligand, along 
with GPI-anchored proteins, to be specifically associated with DRMs366. This suggests 
that the sterol linkage may be an efficient raft-targeting signal. Indeed, Hh that is not 
modified by cholesterol is capable of signaling, but addition of a cholesterol moiety 
increases dramatically its potency in signal transduction367, raising the possibility that the 
efficiency of Hh signaling may depend on its localization to membrane lipid rafts. 
Similarly, in a rat hepatic stellate cell line, Shh interacts with caveolin-1 to form a protein 
complex that associates with lipid membrane rafts368. In adult rat brains, Shh was also 
found to partition with the raft component ganglioside GM-1 during Triton X-100 
solubilization and sucrose density gradient centrifugation. Disruption of Shh association 
with the plasma membrane leads to a reduction in Shh secretion369,370, further suggesting 
that lipid raft microdomains are important in Shh signaling. 
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Due to the high affinity of the Hh ligand to the membrane component, mature Hh 
proteins can remain tethered to the cell surface of the producing cell. Association of Hh 
with DRMs has been proposed important for Hh packing into high order aggregates370-372. 
Release of the soluble Hh is an active and controlled process which requires the action of 
Dispatched, a protein containing sterol-sensing domain365. In fact, Dispatched was 
recognized to package Hh ligands into different soluble forms such as micellar multimers 
or lipoprotein particles371. While Hh multimers consists of a multimerization of the Hh 
protein via its lipophilic tails, Hh ligands can also get solubilized and integrated into 
lipoproteins particles371. In cell cultures, mammalian Hh was indeed found to from highly 
diffusive, biologically active aggregates of a high molecular weight373. Lipoproteins are 
assemblies of lipids and proteins and high and low density lipoproteins (HDL and LDL, 
respectively) allow intercellular transport of water-soluble lipids, cholesterol and 
signaling metabolites throughout aqueous circulation365,372. Although no Hh ligands have 
yet been identified in HDLs, Hh has been found to associate with LDL particles372.  
Interestingly, HDLs have anti-inflammatory properties maintain EC integrity and 
reduces the expression of adhesion molecules in ECs, inhibiting blood cell adhesion to 
vascular endothelium374,375. Vitamin B3 and Niaspan treatments raise levels of protective 
HDL and are proposed to prevent demyelinating diseases and promote health of myelin 
sheaths269,376. In particular, Niaspan has been found to increase Shh levels269, suggesting 
that the anti-inflammatory properties of HDL could plausibly be due to the transport of 
Shh in these HDL, thus increasing the signaling abilities of Shh. 
Membrane lipid rafts can also include other components of the Hh signal 
transduction pathway. Many receptors and G-proteins coupled receptors are found to be 
concentrated in lipid rafts in order to facilitate protein-protein interactions and signaling 
events. Similarly to our own DRM isolation and proteomic analysis, which identified the 
presence of Hip in lipid membrane raft microdomains of ECs of the BBB, Hip was found 
in raft-like microdomains of Human embryonic kidney (HEK) cells369. Caveolin-1 may 
be integral for sequestering the Hh receptor complex in these lipid-enriched 
microdomains, which act as a scaffold for the interactions with the Hh protein. Both Smo 
and Patched-1 are also found in caveolin-1/cholesterol-rich membrane microdomains377. 
While ptch-1 associates and interacts directly with caveolin-1, as the two proteins 
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coprecipitate and colococalize, Smo does not377. However, lipid raft microdomains 
appear to play a role in assembling Hh receptors on the target cell. Cyclopamine, a sterol-
related protein, is capable of exogenously modifying Smo activity, possibly through its 
targeting to Hh-receptor enriched lipid membrane rafts. Recent finding have suggested 
that Ptch-1 endogenously regulates the secretion of small lipophilic molecules, such as 
vitamin D3 or other oxysterols, in order to modulate Smo activity, a process that could 
easily occur in lipid raft signaling platforms159,161.  
 Although our candidate list of proteins found in lipid rafts of BBB-ECs did not 
contain proteins of the Wnt signaling pathway, it is not impossible that these signaling 
platforms also act in regards to other morphogens important in BBB function. 
Comparable to Hh ligands, Wnt proteins are doubly N-glycosylated and bear palmitate 
and palmitoylate groups372,378. The physical properties of these lipid anchors can likely 
promote ligand localization to particular membrane rafts. In vivo, both Wnt and Hh 
ligands bind to the cell surface and can associate and partition with DRMs, suggesting 
their presence in membrane lipid rafts366.  
 
2.1 The Hh signaling pathway in the BBB 
 
In Part II, I demonstrate that astrocyte-derived Shh acts on human BBB-ECs to 
decrease permeability of the BBB to soluble factors in vitro and in vivo, a process that is 
Smo-dependent. This effect is driven by the ability of Shh to induce and maintain TJ 
protein expression. I further demonstrate that Shh regulates BBB-EC activation by 
lowering their expression of surface CAMs and secretion of pro-inflammatory 
chemokines. Consequently, a decrease in transmigrating lymphocytes across the BBB-EC 
monolayer is observed, suggesting that Shh acts as a direct negative regulator of CNS 
inflammation. Downstream transcription factors Gli-1 and SOX-18 are upregulated upon 
Hh activation, implying a mechanism of action. In inflammatory contexts, an increase in 
Shh was observed when human astrocytes were cultured in the presence of inflammatory 
cytokines TNF-α and IFN-γ. Surface expression of both Ptch-1 and Smo were also 
increased in BBB-ECs treated with the same cytokines. However, in MS plaques, while 
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hypertrophic astrocytes upregulated Shh expression, ECs were not found to 
correspondingly increase the expression of the receptors, Ptch-1 and Smo.  
The anatomical proximity of the astrocytic endfeet to the CNS-ECs has lead to the 
notion that astrocytes impact on BBB properties. Astrocyte-derived soluble factors have 
been shown essential for the development and maintenance of an impermeable BBB as 
ACM induces junction formation and strong transendothelial electrical resistance in 
either CNS or non-CNS-derived ECs, in vitro24,312,313. Other morphogens and neural cues 
have previously been linked to cooperate in astrocyte-endothelial interactions. Proteins of 
the FGF family were found to decrease the permeability of the BBB in vitro103. Similarly, 
conditioned media containing Wnt3a induces TJ strand formation, junctional protein 
expression and BBB-EC morphology142. Although human and mouse astrocytes have 
previously been shown to express Shh258,265, its impact on BBB-ECs has not yet been 
studied. 
Shh has been involved in a multitude of developmental processes, ranging from 
embryonic tissue patterning, ventralization of neural tube, and establishment of posterior 
identity in the developing limb bud 152,314. Others have found that Shh can induce 
capillary morphogenesis182, a process which requires promoting assembly via cell-cell 
contact, a process not distant from barrier morphogenesis, where this cell-cell contact is 
further enforced by junctional proteins. Therefore, as a morphogen, Shh dictates 
positional information to individual or groups of cells and how these should assemble to 
form a functional tissue or unit. It is perhaps not striking that Shh can impact on CNS-EC 
to guide them to behave and function as barrier cells. Evidence that Shh may be involved 
in maturation of endothelium can be seen in developing mouse models. In the developing 
mouse submandibular gland, lumen formation and TJ assembly occurs in the epithelial 
cell lining, processes dependent on Shh. Shh null mice had developmental arrested 
submandibular gland epithelium, and treatment with Shh recovered and enhanced 
epithelial lumen formation, cell polarization as well as ZO-1, claudin-3 and occludin TJ 
protein distribution205. As a mature vascular bed, ECs do not behave independently of 
one another; rather they form a monolayer that prevents movement of protein, fluid and 
cells from the endothelial lumen into the surrounding tissue. This can be seen upon Hh 
activation in the PNS where Dhh, expressed in myelinating Schwann cell, is needed for 
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the formation and maintenance of the perineurium, a component of the blood-nerve 
barrier. Dhh -/- animals have a less compact perineurium, resulting in abnormal and 
interrupted TJ strands. Consequently, a defective nerve-tissue barrier is formed and 
extravasation of Evans Blue dye and immune cells invasion into the endoneurium 
occurs206. Therefore, my data further demonstrates the potential of the Hh pathway in the 
formation of a mature, ordered and functionally competent barrier. I demonstrate that 
astrocyte-derived Shh decreases permeability of soluble tracers in the modified Boyden 
chamber assay, an in vitro model of the BBB (Figure 2A). Cyclopamine-injected mice 
endure acute BBB disruption as FITC-Dextran and endogenous serum proteins enter the 
brain parenchyma (Figure 2D-E). Indeed, Hh activation is essential for TJ expression, as 
cyclopamine induces a downregulation of junctional proteins in BBB-EC (Figure 3B). 
Shh -/- mice exhibited a significantly lower expression of claudin-5, occludin and Z0-1 
on BBB-ECs in vivo (Figure 3C-D), confirming the validity of the in vitro observation.  
 The activation of the Hh pathway involves activation of the downstream 
transcription factor Gli-1 which act as an activator to mediate and/or amplify the Hh 
signal as it is transcriptionally induced by Hh signaling in nearly all contexts 
examined315. My data using flow cytometry demonstrates that Hh activation in BBB-ECs 
induces an intracellular upregulation of Gli-1, which is cyclopamine-sensitive (Figure 
5A). However, further mechanisms in promoting BBB properties were sought. SOX-18 
was found to be an endothelial specific transcription factor as in silico analysis of the 
claudin-5 promoter revealed an evolutionary conserved SOX consensus binding site. In 
HUVECs, SOX-18 overexpression increases claudin-5 mRNA and protein expression 
while SOX-18 silencing reduces claudin-5 transcription and transendothelial 
resistance310. My results suggest that Gli-1 activation proceeds SOX-18 upregulation 
(Figure 5C). Whether or not Gli-1 directly upregulates SOX-18 is still not known but in 
different contexts, the Hh pathway has already been seen to regulate other members of 
the SOX family. Shh was seen to induce changes in families of transcription factors such 
as SOX, further altering the expression of downstream genes316. Expression of SOX-14 in 
spinal cords was found to be regulated by Shh in a dose-dependent manner317. In 
neuroepithelial cells Gli-2 binds to an enhancer region vital for SOX-2 expression 
necessary for NSC proliferation and differentiation318.  
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In addition to Gli-1 activation, other non-canonical Hh signaling pathways have 
been described in migrating cells. Although Gli-1 activation was studied in BBB 
formation, other pathways may be involved. In fibroblast cell lines, Shh signals via Smo 
to induce alterations in cell morphology, cytoskeleton rearrangement and lamellipodia 
formation, a process which is transcription/translational-independent. However, rather 
than Gli-1 activation, Shh-induced migration employed the metabolism of arachidonic 
acid through the 5-lipoxygensase pathway192. In axon guiding, Shh stimulates the activity 
of Src family kinases members, also in a Smo-dependent manner379. Furthermore, 
additional receptors at the surface of the target cell are known to transduce Hh signals. 
Boc and Cdo are coreceptors and positively transduce the Hh signal via Gli-1 or Src 
family kinases and can regulate membrane proteins and cytoskeleton remodeling162,379. 
Coupling of these coreceptors with Ptch-1 may also integrate the Hh pathway with other 
signaling cascades as extracellular domains of Cdo and Boc mediate their 
heterodimerization and are able to associate with cadherins and netrins380. Although Boc 
and Cdon have yet to be described in ECs, these receptors could provide an elegant 
method for Hh to execute morphological changes and transcriptional programs, in 
addition to integrating responses with other signaling cascades162.  
2.2 The Hh signaling pathway in MS 
 
 The BBB is an important entity in keeping the CNS an immunologically 
privileged site, a region where immune cells access is infrequent, as opposed to most 
organs319. Astrocytes are key regulators of BBB functions and have been shown to 
secrete a variety of different factors that help promote and maintain BBB 
properties11,24,312,313. However, less often are the factors shown to regulate the immune-
quiescence properties of BBB-ECs. Although extensively studied in embryogenesis, Shh 
has been shown to be expressed in adult tissues and to be involved in tissue 
morphogenesis and repair after injury154,321,381,382. I present evidence suggesting a novel 
and unique role of Shh in the regulation of CNS immunity. During CNS inflammation 
such as MS, its animal model EAE, and following various cerebral insults, surface CAMs 
involved in immune cell diapedesis, ICAM-1 and VCAM-1, are dramatically upregulated 
on BBB-ECs217,325. Similarly, in vitro treatment of BBB-ECs with pro-inflammatory 
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cytokines such as TNF-α and IFN-γ have also been shown to strongly enhance 
endothelial CAM expression23. The anti-inflammatory cytokines IFN-β as well as 
glucocorticoids, lead to a significant reduction in CAM expression, leading to a 
subsequent reduction in leukocyte migration241,383-385. My results show that BBB-ECs 
grown with ACM or treated with rhShh or a Smo agonist, purmorphamine, all activate 
the Hh pathway and lessen the expression of ICAM-1 and VCAM-1 (Figure 4A-B), 
demonstrating anti-inflammatory potential.  
 BBB-ECs are also potent local producers of chemokines that can influence the 
recruitment, activation and migration of immune cells into CNS tissue224,225,320. During 
MS, various chemokines and chemokine receptors have received special attention as key 
regulators of cellular infiltration. MCP-1/CCL2 and IP-10/CXCL10 have been detected 
within active MS plaques, while MCP-1/CCL2 and IL-8/CXCL8 have been found in the 
CSF of MS patients386-388. MCP-1 is a C-C chemokine that has preferential affinity for 
the chemokine receptor CCR1, 2 and 4 and has been shown to increase transendothelial 
migration of CD4+ lymphocytes in chemotaxis assays389. In fact, blocking MCP-1 with an 
anti-MCP-1 antibody reduces the severity of EAE and significantly inhibits by 60% the 
rate of migration of MS lymphocytes across BBB-EC monolayers320. I chose to focus our 
attention on the chemokines MCP-1/CCL2 and IL-8/CXCL8 for they were found to be 
important chemokines produced by BBB-ECs grown under culture conditions 238,320. 
BBB-ECs treated with hrShh or with purmorphamine significantly reduce the secretion of 
both MCP-1/CCL2 and IL-8/CXCL8 (Figure 4C), further demonstrating another mode of 
anti-inflammatory action. The fact that both adhesion molecules expression and 
chemokine secretion decreased tends to signify that BBB-ECs are less effective in 
recruiting lymphocytes to the site of inflammation, an act that was indeed observed in 
vitro. BBB-ECs are also known to be able to produce anti-inflammatory cytokines 
themselves, such as IFN-β and TGF-β390, and it would be of interest to determine if 
activation of the Hh pathway could in turn upregulate the expression of additional potent 
anti-inflammatory signals. Interestingly, TGF-β can induce activation of Gli-1 and Gli-2 
in various cancer cell lines, independent of Hh receptor activation391, suggesting a 
possible anti-inflammatory feedback loop. Therefore, the next logical step in exploring 
the anti-inflammatory effect of the Hh pathway in BBB-ECs would be to assess whether 
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Hh activation could prevent or lessen the expression of adhesion molecules and 
chemokine secretion produced by an inflammatory insult.  
In MS, BBB breach concurs alongside with EC activation and lymphocyte 
infiltration. Since the Hh pathway seems capable of promoting barrier properties as well 
as reducing EC activation and lymphocyte recruitment, I observed the effect of 
inflammation on Hh components. I showed that human astrocytes exposed to TNF-α and 
IFN-γ upregulate Shh production (6A). This was paralleled in situ by the increase in Shh 
immunoreactivity around blood-vessels in active MS lesions, when compared to NAWM 
of the same patient (Figure 7A-C). As Shh has often been observed to be upregulated in 
various cells after acute injury and wound healing, implicating an important role in 
cellular and tissue repair154,256, I postulate that inflammatory cytokines activate Shh 
production in astrocytes in order to possibly aid in repairing BBB damage. Shh thus may 
serve a protective function in acute injury, such as in the liver322, endothelium382 and 
spinal cord injury381. Indeed, a stable form of Shh was injected to treat nerve injury321.  In 
addition, due to its potential anti-inflammatory activity, Shh upregulation could also be 
beneficial in regulating and containing the inflammation.  
 In contrast, while BBB-ECs treated with TNF-α and IFN-γ upregulated both Ptch-
1 and Smo on their surface (Figure 6B), the same could not be seen in vivo, in active MS 
lesions (Figure 8A-B). This demonstrates a potential dysregulation of the pathway at the 
level of the BBB, and provides a plausible explanation to BBB compromise. Further 
investigation of MS material, as well as examination of other CNS inflammatory and 
non-inflammatory diseases, is necessary to fully comprehend the expression pattern. 
Recent studies have observed that Gli-1 was upregulated in active MS lesions, but was 
significantly downregulated in chronic active and inactive lesions265, suggesting that long 
term inflammation impairs Gli-1 signal in chronic inflammatory conditions.    
Other studies have, in fact, observed Shh upregulation after inflammation. IFN-γ 
expression linked to the GFAP promoter in perinatal CNS greatly upregulates Shh 
expression in the developing cerebellum392,392,393. In chronic gastrointestinal 
inflammation, Shh is also upregulated in epithelium of areas of inflammation such as in 
gastritis, Crohn’s disease and ulcerative colitis, an effect that was linked to the ability of 
injury-related cytokines to induce Hh production322. Ptch-1 mRNA and protein 
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expression were absent in inflamed colonic epithelium, similarly to MS endothelium323. 
In a hypothetical model, it was suggested that injured epithelium, via the release of Shh, 
may communicate damage to both neighboring cells and to the immune system such as 
CD4+ T lymphocytes and macrophages that express Ptch-1 and thus capable of 
processing a Shh signal, a process that could further aid in repairing damaged epithelium 
322-324.  
 In a spontaneous acute EAE mouse model, vitamin B12 together with IFN-β 
treatment upregulated Shh and reduced immune cell infiltration and general EAE scores, 
compared to single treatments268. The authors explained the beneficial effect of this 
combinational therapy as the ability of Shh to enhance oligodendrocyte maturation and 
thus, promoting oligodendrocyte remyelination268. However, a reduction of clinical score 
is a rapid process that involves immune and/or barrier modulation. Thus, the upregulation 
of Shh could lead to immunoregulation and barrier stabilization effects which would 
explain the decrease in infiltration and EAE scores seen. In fact, in a chronic EAE model, 
an identical combination therapy was capable of reducing the frequency of multiorgan 
inflammatory lesions (heart, liver, lungs and salivary glands - all organs which express 
Shh), suggesting a general immunomodulatory effect, possibly via Shh268.  
 Shh has been classified as a classical stem molecule394 and embryonic stem cells 
are known to promote immunoprivilege sites395,396, possibly implying a role of Shh in 
immunomodulation and decreasing immune reactions. However, little is known on the 
relationship between the immune system and the Hh signaling pathway. T-cell 
development is regulated, in part, by Shh, and studies have shown the importance of the 
Hh pathway in maintaining immature immune cell populations163,397. In fact, Shh 
influences very early lymphocyte development as Shh -/- thymi at E13.5 were smaller 
than that of littermates, but contained a reduced amount of cells of haematopoietic 
origin398, suggesting that Shh is necessary for their development prior or during entry of 
thymocyte progenitors to the thymus. Later in development, Shh protects germinal-centre 
B cells from apoptosis399. While addition of rhShh to CD4+ T cell populations in vitro has 
shown to enhance induction of T cell activation and proliferation400, other studies have 
seen that constitutive Gli-2 activity in T cells inhibited T cell activation and 
proliferation401.  
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 Although studies have examined the expression of Hh components in EAE, the 
effects of modulating pharmacologically the Hh pathway, with use of Smo agonists and 
antagonists, on the disease evolution have not yet been verified. Keeping in line with 
these current results, I expect that Hh activation would prove to have beneficial and 
neuroprotective effects by stabilizing the BBB. PTX is widely used for the induction of 
EAE by increasing BBB permeability246,247. While the exact mechanism of action is 
unknown, PTX blocks the interaction of G proteins with their G protein coupled 
receptors. Smo, the signal transducer of the Hh pathway is a protein related to a G protein 
coupled receptor158. PTX has been shown to affect and inhibit Smo. Thus, it would be of 
interest to investigate if cyclopamine can efficiently replace PTX to induce BBB 
permeability.  The Hh pathway acts also in reducing inflammation and activation statuses 
of the BBB and potentially of the immune cells. Cyclopamine could thus aggrevate the 
disease, while purmorphamine could prevent or delay disease susceptibility. Both MOG-
induced and PLP-induced EAE could be performed to evaluate the acute and chronic 
models, respectively. Neuropathological studies on the CNS of such mice should be 
performed to evaluate the extent of demyelination, immune cell infiltration, as well as 
BBB dysfunction (serum protein extravasation, junctional proteins expression and EC 
death/apoptosis).  
Identifying factors that are required for BBB integrity is necessary in our 
understanding of neuroinflammation and specifically MS. These experiments allowed us 
to determine that the Hh pathway is an important astrocytic contributor to BBB 
maintenance and function. These data also suggest that Shh acts as a direct negative 
regulator of CNS inflammation through its regulatory effect on BBB-EC activation. This 
work will help in the development of strategies to regulate the migration of immune cells, 
the delivery of drugs across the BBB and to design new therapies in the treatment of 
neuroinflammatory diseases such as MS. 
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